Articles & News

• Laura Delano, author of Unshrunk: A Story of Psychiatric Resistance, on Michael Smerconis Sirius Radio, March 28, 2025.
• Psychiatry stripped naked: Current human rights violations in psychiatry in Germany, Greece and the rest of the world, by Peter Lehmann, Journal of Critical Psychology,Counselling and Psychotherapy, Vol. 24, No. 1, 16-37 (2024).
• New Federal Guidance for Alternatives to Police for People with Behavioral Health or Other Disabilities, by Judge Bazelon Center for Mental Health Law and Vera Institute Justice, January 14, 2025.
• When There’s a Crisis, Call a Peer: How People with Lived Experience Make Mental Health Crisis Services More Effective, Judge Bazelon Center for Mental Health Law, January 3, 2024.
• Report on Improving Mental Health Outcomes, by James B. (Jim) Gottstein, Esq.; Peter C. Gøtzsche, MD; David Cohen, PhD; Chuck Ruby, PhD; Faith Myers, September, 2023.
• OPINION: The rights of Alaskans with mental illness are being violated – by the state, the courts and their own attorneys, Val Van Brocklin, Anchorage Daily News, April 3, 2023.
• Letter to United States Senators Wyden and Crapo regarding their Unmet Mental Health Needs Request for Information, November 1, 2021.
• Video: Soteria Past, Present, and Future: The Evidence For This Model of Care, by Robert Whitaker, July 16, 2021.
• Relief for Acute Psychotic Experiences: Stabilizing Homes - The Soteria Model, National Associatioin on Mental Illness Washington 2021 State Conference October 16 2021.
• What Happened to Britney Spears can Happen to You, by Jim Gottstein, RxISK, August 2, 2021.
• A conversation on Britney Spears, conservatorship, and psychiatric power, Laura Delano, David Cohen, PhD, & Jim Gottstein, June 28, 2021.
• Meta-analysis of the strength of exploratory suicide prediction models; from clinicians to computers, by Corke, M., Mullin, K., Angel-Scott, H., Xia, S., & Large, M. (2021).
• Prohibition of Involuntary Hospitalization and Involuntary Treatment: Countering Misapprehensions-- A briefing paper addressed to the Committee on the Rights of Persons with Disabilities and other stakeholders, by Tina Minkowitz, July 13, 2020.
• Systematic violations of patients’ rights and safety: Forced medication of a cohort of 30 patients, by Peter C Gøtzsche and Anders Sørensen, Indian Journal of Medical Ethics Online First Published August 12, 2020.
• MindFreedom International Organizing Guide for Psychiatric Survivors.
• Treatment Planning and Medication Monitoring Were Lacking for Children in Foster Care Receiving Psychotropic Medication, by the Office of the Inspector General, U.S. Department of Health and Human Services, September 17, 2018.
• Psychotherapy v. Medications: Let us Court the Ways, National Alliance of Professional Psychological Providers, Feb, 2017, Vol 12 No. 2.
• "Prior psychiatric treatment was the single strongest predictor of suicide death," J.D. Ribeiro, J.C. Franklin, K.R. Fox, K.H. Bentley, E.M. Kleiman, B.P. Chang, and M.K. Nock, Letter to the Editor, Psychological Medicine, 46 (2016).
• Opinion: Misguided mental health system needs an overhaul, by Jim Gottstein, January 13, 2016, Alaska Dispatch News.
• Escape from British Columbia, Rob Wipond, Focus, November-December, 2016.
• The Case Against Antipsychotics: A Review of Their Long-term Effects, by Robert Whitaker, Mad In America Foundation, July, 2016.
• Open dialogues in the present and the future – new developments, byJaakko SeikkulaMay 13, 2016.
• The Search for Schizophrenia Genes: Larger and larger samples are showing smaller and smaller effect sizes. What does this mean for drug development, clinical practice, and our view of mental illness? by Jonathan Leo, Slate, February 5, 2016.
• PsychRights and Committee for Truth in Psychiatry submission to FDA opposing reclassification of electroshock machines, March 25, 2016.In search of an evidence-based role for psychiatry, by John  Read, Olga Runciman, & Jacqui Dillon, Future Science, February 22, 2016 (online).
• Soldiers Of The Iraq/Afghanistan Era Dead Of Sudden Cardiac Death Probably Due To Prescription Antipsychotic & Other Psychotropic Drugs, by Fred A. Baughman, Jr., MD, Presented at the 22nd Annual Combat Stress Conference May 1-3, 2015 Carlsbad, CA.
• Drugging Our Kids: Children in California’s foster care system are prescribed unproven, risky medications at alarming rates, story by Karen De Sa, San Jose Mercury News, August 25, 2014.
• Feds Pay for Drug Fraud: 92 Percent of Foster Care, Poor Kids Prescribed Antipsychotics Get Them for Unaccepted Uses, by Art Levine, Huffington Post, April 30,2015.
• Letter From Nine Mental Health Experts To Funders And Ethics Committee About Ketamine + Electroshock Therapy Study, John Read Blog, June 21, 2014.
• Revisiting a debate: Does psychiatry overmedicate? by Stacey Burling, The Philadelphia Enquirer, April 10, 2014.
• The Drugging of the American Boy, Esquire, by Ryan D'Agostino, March 27, 2014.
• Department of Justice letter stating askin about psychiatric diagnosis on bar application violates federal law, January 21 2014.
• Barry Pollack letter to the Commissioner of the Massachusetts Department of Mental Health regarding the abuses by Boston Children's Hospital at its Bader 5 psychiatric ward, December 21, 2013.
• A psychiatrist thinks some patients are better off without antipsychotic drugs, by Sandra Steingard, The Washington Post, December 9, 2013.
• J.&J. to Pay $2.2 Billion in Risperdal Settlement, by Katie Thomas, The New York Times, November 4, 2013.
• Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations Allegations Include Off-label Marketing and Kickbacks to Doctors and Pharmacists, Department of Justice, November 4, 2013.
• PsychRights' Open Letter to Senator Lisa Murkowski (R Alaska), January 21, 2013.
• PsychRights' Letter to the President's Task Force on Gun Violence, January 7, 2013.
• Doctors: Anti-psychotic meds overused for dementia, kids, USA Today, September 21, 2013.
• Seventh Circuit Rules Psychiatrists Commit Medicaid Fraud By Prescribing Psychiatric Drugs Off-Label to Children, August 29, 2013.
• Opinion in Ex rel Watson v. King-Vassel, August 28, 2013.
• U.S. Probes Use of Antipsychotic Drugs on Children, by Lucette Lagnado, The Wall Street Journal, August 11, 2013.
• A Nation of Kids on Speed: Six million children in the U.S. have already been diagnosed with ADHD. Plenty more will follow,by Pieter Cohen and Nicolas Rasmussen, The Wall Street Journal, June 16, 2013.
• Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk, by Tracy Weber, Charles Ornstein and Jennifer LaFleur ProPublica, May 11, 2013.
• Psychiatry’s Guide Is Out of Touch With Science, Experts Say, by Pam Belluck & Benedict Carey, The New York Times, May 6, 2013.
• May 3, 2013, Complaint in Marcus Class Action Against Forest Labs about pediatric use of Lexapro.
• Dangerous Meds for Children Constitute Medicaid Fraud, by Salvatore Pizzuro, April 29, 2013 The New Jersey Newsroom.
• US sues Novartis in NY again, cites doc kickbacks, April 26, 2013, Associated Press.
• Updated list of Soldiers/Veterans Dying of Probable Sudden Cardiac Death, by Fred Baughman, MD, April 17, 2014.
• Psychiatric Asbos' (Outpatient Commitment) were an error says key advisor: Former champion says public safety fears led to adoption of measures that seriously curtailed patients' freedoms, The Independent, April 14, 2013.
• Statement by Mr. Juan E Méndez, Special Rapporteur On Torture And Other Cruel, Inhuman Or Degrading Treatment Or Punishment, 22nd session of the Human Rights Council of the United Nations, March 4, 2013, Geneva.
• The Op-Ed: Antidepressants & Controversial Studies, by Ed Silverman, Pharmalot, February 11, 2013.
• PsychRights' Open Letter to Senator Lisa Murkowski (R Alaska), January 21, 2012.
• Suicidal Teens Plagued by Improper Treatment Strategies, by Elizabeth Lopatto, Bloomberg News, January 09, 2013.
• Psychiatrist Goran Isacsson withheld and destroyed unwanted research data about antidepressants and suicide, by Janne Larsson, January 3, 2013.
• PsychRights' Letter to the President's Task Force on Gun Violence, January 7, 2013.
• Predicting violence is a work in progress, by David Brown, The Washington Post, January 3, 2013.
• Suggestions to the Human Rights Committee for disability-related questions to consider for its List of Issues for the United States, December 28, 2012, from the Center for the Human Rights of Users and Survivors of Psychiatry (CHRUSP), Law Project for Psychiatric Rights (PsychRights), Voices of the Heart, Mind Freedom International, Repeal Mental Health Laws, World Network of Users and Survivors of Psychiatry (WNUSP) and International Disability Alliance.
• Adult antidepressants suspected in suicides of Canadian kids, by Jesse McLean, David Bruser, Toronto Star, December 8, 2012.
• Psychiatry beyond the current paradigm, by Pat Bracken, Philip Thomas, Sami Timimi, Eia Asen, Graham Behr, Carl Beuster, Seth Bhunnoo, Ivor Browne, Navjyoat Chhina, Duncan Double, Simon Downer, Chris Evans, Suman Fernando, Malcolm R. Garland, William Hopkins, Rhodri Huws, Bob Johnson, Brian Martindale, Hugh Middleton, Daniel Moldavsky, Joanna Moncrieff, Simon Mullins, Julia Nelki, Matteo Pizzo, James Rodger, Marcellino Smyth, Derek Summerfield, Jeremy Wallace and David Yeomans, British Journal of Psychiatry, 201,430–434 (2012).
• Time to rethink mental health laws for treatment without consent, by Bernadette McSherry, of Monash University, in The Conversation.
• Antipsychotic Use Spikes in Medicaid-Enrolled Children, by Heidi Splete, Clinical Psychiatry News, October 3, 2012.
• First Risperdal Trial Ends With Settlement, by Amaris Elliott-Enge, The Legal Intellegencer, October 5, 2012.
• The drugs don't work: a modern medical scandal. The doctors prescribing the drugs don't know they don't do what they're meant to. Nor do their patients. The manufacturers know full well, but they're not telling, by Ben Goldacre, The Guardian, September 21, 2012.
• Psychiatric training and treatment under the microscope, by Jan Petter Myklebust, University World News Global Edition, September 16, 2012.
• Raising the Ritalin Generation, by Grownwen Hruska, The New York Times, August 18, 2012.
• More Kids Taking Antipsychotics for ADHD: Study, by Steven Reinberg, HealthDay,
  Aug. 07, 2012
• Two Who Resigned From DSM-5 Explain Why, July 11, 2012, Psychology Today.
• Glaxo Agrees to Pay $3 Billion in Fraud Settlement, by Katie Thomas and Michael S. Schmidt, The New York Times, July 2, 2012.
• 4-year-old Texas girl taken from parents and heavily drugged by Child Protective Services, May 18, 2012, RT News.
• 'Label jars, not people': Lobbying against the shrinks, by James Davies, May 17, 2012.
• 3-year-old in CPS' care overprescribed psychotropic drugs, Fox News Houston, May 16, 2012.
• Abbott Laboratories to pay $1.6 billion over misbranding drug, b Terry Frieden, CNN Justice Producer, and Tom Watkins, CNN, May 7, 2012.
  • Department Of Health Care Services Announces Multimillion-Dollar Settlements With Abbott Laboratories, California Department of Health Care Services, May 7, 2012.
• Video: Mind Over Meds, Part 1, KTUU, Anchorage, Alaska NBC affiliate, May 7, 2012.
• Video: Mind Over Meds, Part 2,  KTUU, Anchorage, Alaska NBC affiliate, May 8, 2012.
• Video:  Mind Over Meds, Part 3, KTUU, Anchorage, Alaska NBC affiliate, May 9, 2012.
• Video:  Mind Over Meds, Part 4, KTUU, Anchorage, Alaska NBC affiliate, May 9, 2012.
• Video: Why are soldiers dying in their sleep?  ABC 11 News, Raleigh-Durham, North Carolina, April 26, 2012.
• Evidence shows that anti-depressants likely do more harm than good, researchers find, McMaster University, April 24, 2012.
• SSRI Benefit in Autism May be Overstated, by Todd Neale, MedPage Today, April 23, 2012.
• PowerPoint: The Mental Health System: Who's Crazy, Jim Gottstein presentation at the Wilda Marston Theater, Anchorage, Alaska April 10, 2012.
• A fog of drugs and war: More than 110,000 active-duty Army troops last year took antidepressants, sedatives and other prescription medications. Some see a link to aberrant behavior, by Kim Murphy, Los Angeles Times, April 7, 2012.
• Video:  Jim Gottstein on the Dan Fagan Show (starting 53 minutes in), April 5, 2012.
• Keeping America’s Children Safe From Abuses In The Use Of Psychotropic Drugs And Seclusion/Restraint, National Association of County Behavioral Health & Developmental Disability Directors, April 1, 2012.
• 30 Minute Video: "Drugging Our Children: Legal and Moral Issues," March 29, 2012, talk by James B. (Jim) Gottstein, Esq., to the American Psychological Association Humanistic Division (Div. 32) annual conference. 
• 9 Minute Video: The Psychiatric Drugging of Children & Elderly, Jim Gottstein discussing the psychiatric drugging of children and youth and the elderly at his guest lecture at Alaska Pacific University, February 22, 2012.
• Doctors not fully told of downside of antipsychotic drugs, study finds: A new report finds that psychiatrists have not been given a full picture of the effectiveness, or lack thereof, of so-called atypical antipsychotic drugs, by Brian Vastag, The Washington Post, March 21, 2012
• Antipsychotic drugs grow more popular for patients without mental illness, by Sandra G. Boodman, The Washington Post, March 12, 2012.
• Are Psychiatric Medications Making Us Sicker? John Horgan, Scientific American, March 5, 2012.
• Opinion: Ritalin Gone Wrong, by L. Alan Sroufe, The New York Times, January 28, 2012.
• Powerful Psychiatrists Push False Theory on Unknowing Souls, by Paula Caplan, PhD, Psychology Today, January 24, 2012.
• Psychiatric Group Push to Redefine Mental Illness Sparks Revolt, by Elizabeth Lopatto, Bloomberg News, January 24, 2012.
• Depression drugs ‘causing falls’ Elderly people with dementia are more likely to suffer falls if they are given anti-depressants by care home staff, a study claims, BBC News, January 18, 2012.
• U.S. to Force Drug Firms to Report Money Paid to Doctors, by Robert Pear, The New York Times, January 16, 2012.
• False Claims, Off-Label Prescribing & DoctorsFalse Claims, Off-Label Prescribing & Doctors, by Ed Silverman, Pharmalot, December 21, 2011.
• Down the Hatch: The Texas Attorney General's Office says a drugmaker lied in order to push an antipsychotic on foster children. So why are kids as young as three still taking the drug? By Craig Malisow published, December 15, 2011.
• Oregon sees drop in the number of foster kids who get psychiatric drug prescriptions, by Michelle Cole, The Oregonian, December 07, 2011
• 20/20 Overmedication in Foster Care, December 2, 2011.
• Video: United States Senate Hearing on The Financial And Societal Costs Of Medicating America’s Foster Children, in the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, December 1, 2011.
  • Written Testimony of the Government Accountability Office (GAO)  Before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate "HHS Guidance Could Help States Improve Oversight of Psychotropic Prescriptions," December 1, 2011.  6 megabytes.
• New Study Shows U.S. Government Fails to Oversee Treatment of Foster Children With Mind-Altering Drugs, Diane Sawyer, ABC News, November 30, 2011.
  • Video: ABC NEWS November 30, 2011 - Psych Drugs - Kids
  • Video: Subcommittee on Federal Financial Management hearing on The Financial And Societal Costs Of Medicating America’s Foster Children
• United States Department of Health and Human Services letter to state Medicaid Directors regarding psychotropic drugs given to children and youth in foster care, November 23, 2011.
• Drugs Used for Psychotics Go to Youths in Foster Care, by Benedict Carey, The New York Times, November 20, 2011.
• 9th Circuit Allows Fraud to Continue; PsychRights Expects To File for Rehearing, October 25, 2011.
• PsychRights Defends Its Whistle-Blower Status, by June Williams, Courthouse News, October 20, 2011.
• Audio of Oral Argument before the United States 9th Circuit Court of Appeals, in PsychRights v. Matsutani, October 12, 2011.
• Rising Mortality Rates for People with Serious Mental Illness, The NeuroCritic, October 11, 2011.
• Military continues off-label drug use, despite concerns,by Bob Brewin, NextGov, September 28, 2011.
• U.S. advisers urge FDA to address antipsychotics in kids, by  Alina Selyukh, Reuters, September 22, 2011.
• Baby deaths spark fears over antidepressants Deaths unexplained; Effexor cited as possible contributor, risk factor, by Kathy Tomlinson,  CBC News, September 20, 2011.
• Are Psychiatric Medications Making Us Sicker? by Dave Plunkert for The Chronicle Review, September 18,2011.
• Jim Gottstein's 2011 NARPA PowerPoint Presentation on "PsychRights' Litigation Against the Psychiatric Drugging of Poor Children & Youth."
• Has Psychiatry Been Corrupted Beyond Repair? fake science is causing real harm, by John D. Gartner, Ph.D, Psychology Today, September 15, 2011
• Full Disclosure Needed About Psychiatric Drugs That Shorten Life Research Shows Some Psychiatric Drugs Decrease Lifespan, by Paula J. Caplan, Ph.D. in Science Isn't Golden Published, Psychology Today, September 4, 2011
• VA spent $717 million on a drug deemed as effective as a placebo, by Bob Brewin NextGov, August 22, 2011.
• Speakers bureau formed to oppose electroshock treatments in Ontario, by John Bonnar, August 18, 2011.
• Major Increase in Hospitalization Rates for Children with Psychiatric Disorders Released, Stony Brook University Medical Center, August 11, 2011.
• Drugs Found Ineffective for Veterans’ Stress, by Benedict Carey, The New York Times, August 2, 2011.
• AstraZeneca Settles Most Seroquel Suits, by Duff Wilson, The New York Times, July 28, 2011.
• Useless Studies, Real Harm, Opinion by Carl Elliott, The New York Times, July 28, 2011.
• Drug firms paid 'independent' experts Practice led to AG-whistleblower lawsuit, by Nanci Wilson, KXAN Austin, July 25, 2011.
• AstraZeneca to Face 2012 Trial in Arkansas Over Sales of Anti-Psychotic, By Sonny Rhodes and Jef Feeley - July 18, 2011
• 'Nobody cared' about her son — until he hanged himself, by  Diana Zlomislic, Totonto News, July 14, 2011
• Mass psychosis in the US: How Big Pharma got Americans hooked on anti-psychotic drugs, by James Ridgeway, Al Jazeera, July 12, 2011.
• Complaint of Scientific Misconduct against Dwight L. Evans, Laszlo Gyulai; Charles Nemeroff, Gary S. Sachs and Charles L. Bowden, to the United States Office of Research Integrity, July 8, 2011.
• Was the order removing Godboldo's daughter from her custody valid? WXYZ, Channel 7, July 7, 2011.
• Response to the American Psychiatric Association: DSM-5 Development, by British Psychological Association  June, 2011.
• The Illusions of Psychiatry, by Marcia Angell, The New York Review of Books, July 14, 2011.Detroit Action News,
• The Epidemic of Mental Illness: Why? June 23, 2011.
• GPs have been urged to review all patients with dementia taking antipsychotic drugs to reduce potential harm from inappropriate prescribing, by Stephen Robinson, GP Magazine, (UK) June 9, 2011.
• Judge orders Johnson & Johnson subsidiary to pay SC $327 million for deceptive drug marketing, by Meg Kinnard, Associated Press, June 3, 2011.
• America's Most Dangerous Pill? by Christopher Byron, The Fix, AlterNet, June 1, 2011.
• Getting personal: Feds pursue top execs in health care fraud cases previously settled for cash, by Associated Press, Published, May 30
• Creating juvenile zombies, Florida-style, by Fred Grimm, The Miami Herald, May 28, 2011.
• Drugging the Vulnerable: Atypical Antipsychotics in Children and the Elderly, By Mala Szalatitz, Time Magazine, May 26, 2011.
• Palm Beach Post Exclusive: Jailed juveniles' doctors draw Medicaid inquiry -- Drugging juveniles: Doctors hired to evaluate kids in state custody have taken huge payments from drug companies, by Michael Laforgia, The Palm Beach Post, May 25, 2011.
• Nearly Half of Kids in Inpatient Psychiatric Program Receive Antipsychotics, by Arline Kaplan, Psychiatric Times, May 23, 2011.
• Huge doses of potent antipsychotics flow into state jails for troubled kids.  Drugging juveniles: Doctors hired to evaluate kids in state custody have taken huge payments from drug companies, by Michael Laforgia, The Palm Beach Post, May 22, 2011.
• Plea to free children from 'chemical cages', by Andrew Taylor, The Sydney Morning Herald, May 15, 2011
• A bitter pill: from depression to obesity, by Mark Metherell, The Sydney Morning Herald, May 14, 2011
• Highlighting Drug Industry Influence, Watchdog Says Overmedication in Nursing Homes Is Troubling, by Marian Wang, ProPublica, May 10, 2011.
  • Overmedication of Nursing Home Patients Troubling, Statement by Daniel R. Levinson, Inspector General, Department of Health and Human Services, May 9, 2011
  • Medicare Atypical Antipsychotic Drug Claims For Elderly Nursing Home Residents, Report by Daniel R. Levinson, Inspector General, Department Of Health And Human Services, Office Of Inspector General, May, 2011.
• Antipsychotic Drugs Called Hazardous for the Elderly, by Gardiner Harris, The New York Times, May 9, 2011.
• So Full of Fail, Disability Rights Center of Arkansas, May 9, 2011.
• Changes To Reimbursement Rules For Prescribing Psychotropic Medications: Small Changes That Can Significantly Reduce Total Healthcare Costs While Increasing The Quality of Care For Patients, by the National Alliance Of Professional Psychology Providers, May, 2011.
• One in four ADHD sufferers 'fake or exaggerate' symptoms for drugs to get high or raise focus, The Daily Mail, April 26, 2011.
• FOIA Friday: The NIH Reacts to "Show Me the Money!" Researcher, Project on Government Oversight, April 22, 2011.
•  Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints, by Aaron S. Kesselheim, Michelle M. Mello, David M. Studdert, PLoS Medicine, April 2011, Vol 8, Issue 4.
• July 30, 2009, letter from National Institute of Mental Health to Emory University.
• The STAR*D Scandal, by Ed Piggot, Ph.D., Mad in America Blog, April 20, 2011.
• STAR*D: A Tale and Trail of Bias, by H. Edmund Pigott, PhD, Ethical Human Psychology & Psychiatry, Vol 13. No. 1:6-28 (2011)
• Link Between Antidepressant Use And Thicker Arteries, Medical News Today, April 3, 2011.
• Study Finds Conflicts Among Panels’ Doctors, by Duff Wilson, The New York Times, March 28, 2011.
• Doctors' Conflicting Interests Can Cost Money and Lives, and Hinder Medical Discoveries: Are Doctors' Industry Ties Influencing Your Care?  Opinion by Stefan Kruszewski, ABC News, March 28, 2011.
• When Government Propaganda Masquerades as Science, by Robert Whitaker, Psychology Today, March 25, 2011.
• Department of Justice Moves to Protect Medicaid Defrauders: Court Sets Hearing for April 7th, Law Project for Psychiatric Rights, March 24, 2011.
• J&J’s Risperdal Letter Violated Consumer Law, Jury Finds, by Jef Feeley and Gary Henderson, Bloomberg News, March 22, 2011.
• J&J Duped South Carolina Doctors Over Risperdal, Lawyer Says, by Jef Feeley and Gary Henderson, Bloomberg News, March 21, 2011.
• AstraZeneca Pays States $68M for Seroquel Probe, Pharmalot, March 10, 2011.
  • Complaint
  • Consent Judgment
• Medical journals still publishing studies that fail to reveal funding: study, by Carly Weeks, The Globe and Mail, March 9, 2011.
• A Sugared Pill, by Andrew Jack, Financial Times, March 8, 2011.
• Reviews of Drug Trials underreport Conflicts of Interest, by Winston Chung, Child Psychiatrist, San Francisco Chronicle, March 8, 2011.
• The Make-Believe Billion: How drug companies exaggerate research costs to justify absurd profits, by Timothy Noah, Slate, March 3, 2011.
• I'm Bipoloar, You're Bipolar: Your mental illness is their financial gain, by Mikkel Borch-Jacobsen, Adbusters, March 2, 2011.
• Physicians: Prescribing Less May Improve Outcomes, Excessive Pills, Overtreatment, May Do More Harm Than Good, Opinion by Stefan P. Kruszewski, M.D., ABC News, February 23, 2011.
• Concern over high medication rate among foster kids: Review of kids’ psych drugs urged, by April Hunt, The Atlanta Journal-Constitution, February 23, 2011.
• For Some Troops, Powerful Drug Cocktails Have Deadly Results, reported by James Dao, Benedict Carey and Dan Frosch and written by James Dao, The New York Times, February 12, 2011.
• Short time on antipsychotics may up heart disease, by Leigh Krietsch Boerner, Reuters Health, February 9, 2011.
• FDA panel advises more testing of 'shock-therapy' devices, by David Brown, Washington Post, January 28, 2011.
  • PsychRights' January 24, 2011, Letter to the FDA regarding reclassification of Electroshock machines.
• Health Advocacy Groups Take Drug Company Cash—Often Without Full Disclosures, Report Says, by Marian Wang, ProPublica, January 13, 2011
• PsychRights' January 24, 2011, Letter to the FDA regarding reclassification of Electroshock machines.
• The Reflexive Call for Fewer Liberties, by Glenn Greenwald, Salon.com, January 12, 2011.
• Crazy Talk, by Vaughan Bell, Slate, January 9, 2011.
• Military Kids Taking More Psychiatric Drugs, by Karen Jowers and Andrew Tilghman, Army Times, January 2, 2011.
• Researcher Finds Evidence Lacking For Widespread Use Of Costly Antipsychotic Drugs, Medical News Today, January 7, 2011.
  • Antipsychotic Medication Use in Medicaid Children and Adolescents: Report and Resource Guide from a 16-State Study, from the Medicaid Directors Learning Network and the Rutgers Center for Education and Research on Mental Health Therapeutics (CERTs), June 2010.
• Judge blocks discovery into aspiring lawyers' mental health, by Leigh Jones, The National Law Journal, January 4, 2011.
• Psychiatrist tries a different approach with dementia patients, by Barbara Peters Smith, The Herald Tribune, January 2, 2011.
• So Young and So Many Pills: More than 25% of Kids and Teens in the U.S. Take Prescriptions on a Regular Basis, by Anna Wilde Mathews, The Wall Street Journal, December 28, 2011.
• Inside the Battle to Define Mental Illness, by Gary Greenberg, Wired Magazine, December 27, 2011.
• Med Schools Flunk at Keeping Faculty Off Pharma Speaking Circuit, by Tracy Weber and Charles Orsntein, Pro Publica, December 19, 2010.
• Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 to 2010, by Sammy Almashat, M.D., M.P.H, Charles Preston, M.D., M.P.H, Timothy Waterman, B.S., Sidney Wolfe, M.D., Public Citizen’s Health Research Group, December 16, 2010.
• Prescription Drugs Associated with Reports of Violence Towards Others, by Thomas J. Moore, Joseph Glenmullen, and Curt D. Furberg, PLoS One Vol 5: 12 (December 2010).
• The Great DNA Data Deficit: Are Genes for Disease a Mirage? by Jonathan Latham and Allison Wilson, The Pioscience Resource Project, December 8, 2010.
• Risks of ECT outweigh benefits, review finds, by Carl Obrien, The Irish Times, December 7, 2010.
• The effectiveness of electroconvulsive therapy:: A literature review, by John Read and Richard Bentall, epidemiologia e Psichiatria Sociale, 19: 4 (2010).
• Some doctors handing out prescriptions to kids for potent medications, by Darren Barbee, Star Telegram (Texas), December 11, 2010.Drug Maker Wrote Book Under 2 Doctors’ Names, Documents Say, by Duff Wilson, The New York Times, November 29, 2010.
  • POGO Letter to NIH, November 29,2010.
• Psychiatric researcher pleads guilty to research fraud, by David Gutierrez, Natural News, November 29, 2010.
• The Problem of Insufficient Reporting and Publication Bias: Published literature tends to overestimate benefits and underestimate harms, by Patricia F. Dimond, PhD., Genetic Engineering & Biotechnology News, November 22, 2010.
• Letter to U.S. Senator Carper on Pediatric Psychopharmacology Medicaid Fraud, November 9, 2010.
• Ex-Glaxo Executive Is Charged in Drug Fraud, by Duff Wilson, The New York Times, November 9, 2010.
  • Indictment
• Lies, Damned Lies, and Medical Science, by David H. Freedman, the Atlantic, November, 2010.
• Firm with Earth City unit [Forest Labs] is settling suits over drugs tied to suicides, by Jim Doyle, St. Louis Today, October 30, 2010.
• First-Time Antipsychotic Use Linked to Rapid Weight Gain, Adverse Metabolic Changes in Kids, by Caroline Cassels, Medscape Medical News, October 29, 2010.
• Psychiatrists Dominate "Doctor-Dollars" Database Listing Big Pharma Payments, by Shelley Wood and Robert Lowes, Medscape Medical News, October 22, 2010.
• Training Lecture on Psychiatric Drugs: the important association between psychiatric drugs, medical illness, and premature death.
• Another Volley in Rx Probe, by Mar Cabra and John Dorschner, The Miami Herald, October 21, 2010.
• Letter from Sen. Charles Grassley to Secretary of Health & Human Services Sebelius regarding prolific Medicaid prescribers, October 20, 2010.
• Prescription for prestige: Drug firms’ speaking fees flow to Harvard doctors; concerns about influence prompt new restrictions, by Liz Kowalczyk, Boston Globe, October 19, 2010.
• Are we medicating a disorder or treating boyhood as a disease? By Carolyn Abraham, The Globe and Mail, October 18, 2010.
• Doctors ignored drugs warnings, by Janice Barker, Oldham Chronicle, October 18,2010.
• J&J Must Pay $257.7 Million Over Risperdal Marketing, by Jef Feeley and Margaret Cronin Fisk, Bloomberg, October 14, 2010.
• Why genes are leftwing; The right loves genetic explanations for poverty or mental illness. But science fingers society, by Oliver James, The Guardian, October 12, 2010.
• Side Effects May Include Lawsuits, by Duff Wilson, The New York Times, October 2, 2010.
• Psych Meds in Jail, Youth Today, October 1, 2010.
• Novartis Pharmaceuticals Corporation to Pay $422.5 Million for off-label Drug Marketing: Company reaches plea and civil settlement agreements, United States Attorney, Eastern District of Pennsylvania, September 30, 2010.
• Government orders action on 'chemical cosh' which kills thousands, London Telegraph, September 25, 2010.
• ADHD: A Global Epidemic or Just a Bunch of Fidgety Kids? by John Cloud, Time Magazine, September 22, 2010.
• Forest, Maker of Celexa, to Pay More Than $313 Million to Settle Marketing Case, by Natasha Singer, The New York Times, September 15, 2010. 
• Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade, by Use Aagaard and Ebba H Hansen, BMC Research Notes (2010).
• Symposium on DSM 5, Part II, Association for the Advancement of Philosophy and Psychiatry, Vol 17, No. 2 (2010).
• Child’s Ordeal Shows Risks of Psychosis Drugs for Young, by Duff Wilson, The New York Times, September 1, 2010.
• The STAR*D Scandal: A New Paper Sums It All Up, by Robert Whitaker, Psychology Today, August 27, 2010.
• Making a Killing: Clinical Trials Have Become Marketing Exercises for Big Pharma-and cash-strapped universites are helping make the sale.  Too bad for Dan Markingson, by Carl Elliot, Mother Jones, September/October 2010.
• Pharmaceuticals: A Market for Producing 'Lemons' and Serious Harm, Analysis Finds, Sciene Daily, August 17, 2010.
• Letter to Senators Kerry and Lugar supporting the ratifiction of the United Nations Convention on the Rights of Persons with Disabilities (CRPD), August 16, 2010.
• Zyprexa Document Leaker Loses His Appeal, by Ed Silverman, Pharmalot, August 13, 2010
  • Statement of Jim Gottstein Regarding 2nd Circuit Decision on the Zyprexa Papers, August 12, 2010
• Charlie Rose and the Mentally Ill, by Robert Whitaker, Psychology Today, August 13, 2010.
• FDA Drug Safety Communication: Aseptic meningitis associated with use of Lamictal (lamotrigine), August 12, 2010.
• Illinois Medicaid Fraud Case Using PsychRights' Model Complaint Unsealed, August 11, 2010
• Some Pharmaceutical Clinical Trial Results Are Buried, Study Shows: Results remain unpublished, hard to find, by Sharon Begley, Newsweek, August 5, 2010.
• Why antidepressants are simply a confidence trick: A leading psychologist claims taking sugar pills would work just as well, by Prof. Irving Kirsch, The Daily Mail, August 3, 2010.
• Studies Halted at Brain Lab Over Impure Injections, by Benedict Carey, The New York Times, by Benedict Carey, July 16,2010.

• Youth Lock-ups Blasted, by Diana Zlomislic, Toronto Star, July 7, 2010.

• Sara Carlin, Paxil And Drug Safety In Canada, by Ed Silverman, Pharmalot, June 30,2010.
• Doc Goes To Jail In Pfizer Research Fraud Case, by Ed Silverman, Pharmalot, June 25, 2010.
• Psychiatric drugs fuel flood of diagnoses, by Dr. Charles Barta, Green Valley News, June 19, 2010.
• Psychotropic Drug Abuse in Foster Care Costs Government Billions, by David Sessions, Politics Daily, June 16, 2010.
• Tracking the American Epidemic of Mental Illness - Part III, by Evelyn Pringle, OpEdNews, June 7, 2010.
• Antipsychotic deflates the brain: Drug for schizophrenia causes side effects by shrinking part of the brain, byAmy Maxmen, Nature News, June 6, 2010.
• Psychiatric Fads and Overdiagnosis, by Allen Frances, MD, Psychology Today, June 2, 2010.
• Tracking the American Epidemic of Mental Illness - Part II, by Evelyn Pringle, OpEdNews, June 2, 2010.
• Medicating Children: A “Whistleblower’s” Lawsuit Raises a Novel Legal Question, by Robert Whitaker, Mad in America blog, Psychology Today, June 2, 2010
• Tracking the American Epidemic of Mental Illness - Part I, by Evelyn Pringle, OpEdNews, June 1, 2010.
• Curbing Drug-Company Abuses: Are Fines Enough? By Ken Stier, Time Magazine, May 30, 2010.
• Summing Up the NIMH Trials: Evidence of an Effective Paradigm of Care? By Robert Whitaker, Mad in America blog, Psychology Today, May 28, 2010.
• Let's Call the Whole Thing Off, by By Irwin Feinberg, MD, Psychiatric Times, May 27, 2010.
• Yet Another Disappointment: First CATIE, and Now the 12-Month Results from TEOSS, by Robert Whitaker, Mad in America blog, Psychology Today, May 25, 2010.
• Psychiatric Drugs and Poor Kids, by Bruce E. Levine, The Huffington Post, May 20, 2010.
• Foster Children Mistreated, Suit Against City Claims, by A.G. Sulzberger, The New York Times, May 12, 2010.
• The DSM5 Field Trial Proposal—An Expensive Waste of Time, by Allen Frances, MD, Psychiatric Times, May 7, 2010
• State of Utah Complaint Against Manufacturers of Risperdal and Seroquel, May 3, 2010.
• So much bluster, but foster kids' drug nightmare continues, by Fred Grimm, The Miami Herald, May 1, 2010.
• Mental Health Group’s State Chapters Get Millions From Pharma, by Katherine Hobson, The New York Times, April 28, 2010.
• AstraZeneca Pays $520 Million to Settle Seroquel Whisteleblower Claims, April 28, 2010.
  • Pharmaceutical Company AstraZeneca to Pay $520 Million for Off-Label Drug Marketing, U.S. Department of Justice, United States Attorney, Eastern District of Pennsylvania, April 27, 2010
  • Settlement Agreement
  • Corporate Integrity Agreement
• "Anatomy of an Epidemic: The hidden damage of psychiatric drugs, by Jed Lipinski, Salon.com, April 27, 2010.
• For $520 Million, AstraZeneca Will Settle Case Over Marketing of a Drug, by Duff Wilson, The New York Times, April 26, 2010.
• Sen. Grassley Letter to the National Alliance for Mental Illness (NAMI), April 26, 2010.
• Pfizer’s Geodon Trial Had ‘Significant Violations,’ by Catherine Larkin, Bloomberg News, April 20, 2010.
• A Psychiatric Revolution, by Andrew Scull, The Lancet, April 10, 2010.
• Red flags overlooked in 12-year-old's prescription drug death, by Carol Marbin Miller, The Miami Herald, April 19, 2010.
• Ethical and Moral Obligations Arising From Revelations of Pharmaceutical Company Dissembling, by James B. Gottstein, JD, Ethical Human Psychology and Psychiatry, Vol. 12, No. 1:22-29 (2010)
• Popular anticonvulsant drugs raise suicide risks, by Julie Steenhuysen, Reuters, April  13 2010
• Feds Found Pfizer Too Big To Nail, by Drew Griffin and Andy Segal, CNN, April 2, 2010.
• The Peer Review "Fig Leaf": Vera Hassner Sharav, by Suzan Mazur, Scoop Independent News, April 1, 2010.
• COMMENTARY: Wholesale sedation of young children medically, morally indefensible, by Larry Diller, The Patriot Ledger, March 27, 2010.
• Civil Minutes Order Denying Motion to Dismiss by Sandoz and Eli Lilly on the grounds that the FDA would not have allowed a warning concerning Prozac’s suicide risks and that a generic manufacturer is not allowed to voluntarily revise its warning label, in Dorsett v. Sandoz, Inc., et al., Case No. CV 06-7821,  (C.D.Cal., March 26, 2010).
• Psychiatrists And Pharma: Undue Influence?  Pharmalot, March 25, 2010.
• Top Scientist Calls for Ethics Cleanup Around "Big Pharma," USA Today, March 23, 2010.
• Medicating the military: Use of psychiatric drugs has spiked; concerns surface about suicide, other dangers, by Andrew Tilghman and Brendan McGarry, Army Times, March 17, 2010.
• FDA Warns Psychiatrist Who Treated Dead Foster Child, by Carol Marbin Miller, The Miami Herald, March 16, 2010.
• Pregnant women warned over Prozac risk to foetus, The London Times, March 12, 2010.
• J&J Pushed Risperdal for Elderly After U.S. Warning, Files Show, by  Margaret Cronin Fisk, Jef Feeley and David Voreacos, Bloomberg, March 10, 2010.
• Nursing home drug use puts many at risk Antipsychotics given to some with dementia, by Kay Lazar, Boston Globe, March 8, 2010
• Does the DSM-IV Clinical Significance Criterion for Major Depression Reduce False Positives? Evidence From the National Comorbidity Survey Replication, by Jerome C. Wakefiield, Ph.D., D.S.W., Mark F. Schmitz, Ph.D., and Judith C. Baer, Ph.D., American Journal of Psychiatry, 167:298-304 (2010).
• Cold Case Files - Paxil Birth Defects, by Evelyn Pringle, Scoop, March 2, 2010
• New York Is Ordered to Move Mentally Ill Out of Group Homes, by A.G. Sulzberger, The New York Times, March 1, 2010.
  • Court Decision, March 1, 2010
  • Court Order, March 1, 2010
• US Seeks More Information About J&J Antipsychotic Marketing, by By Peter Loftus, The Wall Street Journal, March 1, 2010.
• It's not too late to save 'normal':Psychiatry's latest DSM goes too far in creating new mental disorders, by Allen Frances, Los Angeles Times (opinion), March 1, 2010.
• Psychiatry's Main Method to Prevent Mistaken Diagnoses of Depression Doesn't Work: Study, Science Daily , February 25, 2010.
• AstraZeneca Tied Studies to Marketing, Witness Says, by Jef Feeley and Margaret Cronin Fisk, Business Week, February 23, 20101.
• Mother Guilty of Murder--Pediatric Bipolar Disorder Innocent, by By Lawrence Diller, M.D., Psychology Today, February 20, 2010.
• Senator Grassley letter to WebMD regarding it conducting the depression screening test developed by Eli Lilly and other ties to industry, February 18, 2010.
• Paxil Birth Defect Litigation - First Trial A Bust for Glaxo, by Evelyn Pringle, Natural News, February 17, 2010.
• Revising Book on Disorders of the Mind, by Benedict Carey, The New York Times, February 10, 2010.
• Lawyer takes on psychiatric industry for over-prescribing foster children, by Rhonda McBride, KTUU, February 11, 2010.
• Alaska psychiatrists accused of wrongly medicating children: FRAUD CLAIM: Doctors followed drug marketing recklessly, suit says, by Megan Holland, Anchorage Daily News, February 11, 2010.
• Revising Book on Disorders of the Mind, by Benedict Carey, The New York Times, February 10, 2010.
• Suing Doctors Who Use Drugs as Chemical Straitjackets for Children, Alison Bass Blog, February 8, 2010.
• AstraZeneca Facing 26,000 Lawsuits Over Seroquel, by Jeff Feeley and Margaret Cronin Fisk, Bloomberg News, February 3, 2010.
• AstraZeneca "Suppressed" Drug Test Data, BBC News, January 26, 2010
• Fattened by Pills: One of the Biggest Causes of Obesity is Seldom Discussed, by Paula J. Caplan, Boston Globe, January 24, 2010.
• Letter from Senator Charles Grassley to the National Institutes of Health, January 20, 2010.
• Johnson & Johnson Accused of Drug Kickbacks, by Natasha Singer, The New York Times, January 16, 2010.
• Doctor Wrote 1,000 Scripts/Week, by Carol Gentry, Health News Florida, January 15, 2010.
• Deal Made to Monitor Brooklyn Hospital, by Anemonia Hartocollis, The New York Times, January 8, 2010.
• Drugs May Aid Only Severe Depression, by Benedict Carey, The New York Times, January 6, 2010.
• More U.S. Patients Receive Multiple Psychotropic Medications, Science Daily, January 5, 2010.
• More Toddlers, Young Children Given Antipsychotics: Researchers Question the "worrisome" Trend, by Jennifer Thomas, Health Day, January 4, 2010.
• Feds investigating high prescribing Fla. docs, by Kelli Kennedy, Associated Press Writer, St. Petersburg Times, December 17, 2009.
• Anti-depressants 'up stroke risk,' BBC, December 15, 2009.
• US Kids Represent Psychiatric Drug Goldmine, by Evelyn Pringle, Truthout, December 12, 2009.
• Poor Children Likelier to Get Antipsychotics, by Duff Wilson, The New York Times, December 12, 2009.
• Psychiatry's Civil War, New Scientist, December11, 2009.
  • Editorial: Time's Up for Psychiatry's Bible, December 11, 2009.
• UIC study alleges an overuse of drugs on juveniles at understaffed Streamwood psychiatric hospital: UIC study says understaffed site overmedicated kids, by David Jackson, Chicago Tribune, December 11, 2009.
• Letter from Sen. Charles Grassley to Laurie Flynn, Executive Director, TeenScreen National Center for Mental Health Checkups at Columbia University, December 7, 2009, regarding pharmaceutical company funding.
• Antipsychotics, Diabetes & Kids, The Wall Street Journal, December 4, 2009.
• Information for Healthcare Professionals: Risk of Neural Tube Birth Defects following prenatal exposure to Valproate, December 3, 2009.
• AstraZeneca Judge to Urge Return of Seroquel Cases to Courts, by Jef Feeley and Margaret Cronin Fisk, Bloomberg News, November 19,2009.
• Doctor-drugmaker ties: Psychiatrist Dr. Michael Reinstein received nearly $500,000 from antipsychotic drug's manufacturer: Company paid him to promote Seroquel despite misgivings about his research, by Christina Jewett and Sam Roe, Chicago Tribune, November 11, 2009.
• Doctor gives risky drugs at high rate: Complaints, suits follow psychiatrist to thousands with serious mental illness, by Christina Jewett and Sam Roe, Chicago Tribune, November 10, 2009
• Pfizer Broke the Law by Promoting Drugs for Unapproved Uses, by David Evans, Bloomberg News, November 9, 2009.
• AstraZeneca Pays Millions to Settle Seroquel Cases, by Duff Wilson, The New York Times, October 30, 2009.
• Weight Gain Associated with Antipsychotic Drugs, by Duff Wilson, The New York Times, October 28, 2009.
• The Loss of Client Agency into the Psychopharmaceutical-Industrial Complex, by Thomas L. Murray, Jr., Journal of Mental Health Counseling, Vol. 31, No. 4: 283-308 (2009).
• Compromised Care: Psychotropic drugs given to nursing home patients without cause: Many Illinois residents get medications they don't need or want. The result? A threat to the lives of our elderly, by Sam Roe, Chicago Tribune, October 27, 2009.
• Drug Makers Are Advocacy Group’s Biggest Donors, by Gardiner Harris, The New York Times, October 22, 2009.
• F.D.A. Lags in Banning Researchers After Fraud, by Gardiner Harris, The New York Times, October 22, 2009.
• Lawsuit Hits Credibility of Pfizer Drug and Research, The (Connecticut) Day, October 4, 2009.
• Bad Medicine (Editorial), St. Petersburg Times, September 21, 2009.
• Opportunity to Object to FDA On Safety of Electroshock Machines
  • Briefing Sheet
• Glaxo Executive’s Memo Suggested Burying Drug Studies, by Jef Feely and Margaret Cronin Fisk, Bloomberg News, September 15, 2009.
• JAMA, Free Speech, and Conflicts of Interest, by Jonathan Leo, Society, 10.1007/s12115-009-9259-9 (2009).
• Lilly Paid Doctors to Prescribe Zyprexa, Notes Show, by Margaret Cronin Fisk and Jef Feeley, Bloomberg News, September 8, 2009.
• Federal Court Decision ruling that New York's larger Adult Homes violate the Americans with Disabilities Act (ADA), September 8, 2009.
• Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger; Editorial from the PLoS Medicine Editors, September 2009 | Volume 6 | Issue 9 | e1000156.
• Justice Department Announces Largest Health Care Fraud Settlement in Its History: Pfizer to Pay $2.3 Billion for Fraudulent Marketing, Department of Justice, September 2, 2009.
  • Third Amended Complaint.
  • Government Intervention with Settlement Agreement
    • Exhibit 1, Settlement Agreement with mutual releases
    • Exhibit 2
  • AIG of Drugmakers Pfizer Is Too Big to Be Guilty, by Ann Woolner, Bloomberg News, September 4, 2009.
  • A Drug Maker's Playbook Reveals a Marketing Strategy, by Gardiner Harris, The New York Times, September 2, 2009.
  • Lexapro Fiscal 2004 Marketing Plan, sent to Sen. Kohl by Sen. Grassley, August 12, 2009.
• A Drug Maker's Playbook Reveals a Marketing Strategy, by Gardiner Harris, The New York Times, September 2, 2009.
  • Lexapro Fiscal 2004 Marketing Plan, sent to Sen. Kohl by Sen. Grassley, August 12, 2009.
• Disparities: Study Finds Risk in Off-Label Prescribing, The New York Times, August 25, 2009.
• Glaxo Used Ghostwriting to Promote Paxil: Offered to help doctors publish articles on drug, by Matthew Perrone, Associated Press/Boston Globe, August 20, 2009.
• Doped and Duped: Adverse effects of widely-prescribed drugs are often overlooked because there is so little truly independent academic evidence, by David Healy, Guardian (UK), August 8, 2009.
• Cheryl Stevens Letter to Oprah Winfrey, August 6, 2009.
• Drug Firms' Medical Staffs Say What Salespeople Can't, by Shirley S. Wang, The Wall Street Journal, June 26, 2009.
• Kids need care, not pills, ex-foster children tell panel, by Amy Sherman, Miami Herald, June 19, 2009.
• Kings County Hospital doctors, nurses facing charges in Esmin Green death-by-neglect case, by John Marzulli, New York Daily News, June 19, 2009.
• Lilly Sold Drug for Dementia Knowing It Didn’t Help, Files Show, by Margaret Cronin Fisk, Elizabeth Lopatto and Jef Feeley, Bloomberg News, June 12, 2009.
• Eli Lilly ‘Ghostwrote’ Articles to Market Zyprexa, Files Show, by Elizabeth Lopatto, Jef Feeley and Margaret Cronin Fisk, Bloomberg News, June 12, 2009.
• FDA Throws Lifeline to Antipsychotic Pushers, by Evelyn Pringle, Counter Punch, June 12, 2009.
• Drug rules to protect kids were ignored, DCF says, by Carol Marbin Miller, The Miami Herald, June 9, 2009.
• When Drug Trials Go Terribly Wrong: Lessons from a Bereaved Mother, Psychology Today Blog, June 8, 2009.
• Foster Care Failures, St. Petersburg Times Editorial, June 7, 2009.
• Lawsuit links psychiatric drugs to Tamarac child's death, by Carol Marbin Miller, The Miami Herald, June 4, 2009.
• Conflicts of interest bedevil psychiatric drug research, USA Today, June 3, 3009.
• Drug Agency May Reveal More Data on Actions, by Gardiner Harris, The New York Times, June 2, 2009.
• DCF's drug records suspect, by Kris Hundley and Connie Humburg, Tampa Bay Times, May 29, 2009.
• AstraZeneca Is Accused Over Seroquel, by Jonathan D. Rockoff, The Wall Street Journal, May 20, 2009.
• Children's Use Of Psychiatric Drugs Begins To Decelerate, by David Armstrong, Wall Street Journal, May 18, 2009.
• Dr. Grace E. Jackson Affidavit on  John R. Weisz and Peter S. Jensen, "Efficacy and Effectiveness of Child and Adolescent Psychotherapy and Pharmacotherapy," Mental Health Services Research 1:3 (1999): 125-157.
• Depraved Indifference: Drunk Driving on the Therapeutic Highway, by Richard Warner, May 14, 2009.
• Drug Limits Skirted for Foster Kids, by Carol Marbin Miller, The Miami Herald, May 8, 2009.
• Massive Medicaid Fraud Exposed: PsychRights Calls on Members of Congress for Assistance, May 5, 2009.
  • May 5, 2009, letters to Senators Charles Grassley and Herb Kohl, and Representatives Henry Waxman, Bart Stupak, John Dingell & Barney Frank
  • Massive Medicaid Fraud Exposed in Psychiatric Drugging of Kids in US, by Evelyn Pringle, LawyersandSettlements.Com, May 8, 2009.
• Broward child's suicide raises questions about medication, by Carol Marbin Miller, The Miami Herald, April 21, 2009.
• Re: Seroquel for Adjunctive Therapy in Major Depressive Disorder, by Dr. Stefan Kruszewski, April 14, 2009, in response to the FDA advisory committee recommending the FDA approve Seroquel for such use.
• Atypical antipsychotics: too hard a sell? by Melissa Healy, Los Angeles Times, April 13, 2009
• Grassley Probes Financing of Advocacy Group for Mental Health, by Nicole Gaouette, Bloomberg News, April 6, 2009.
  • Letter from Senator Grassley to the National Alliance on Mental Illness, April 6, 2009.
• To Move More Prescription Drugs, Sales Reps Sling Swag, by Kris Hundley, St. Petersburg Times, April 5, 2009.
• Conflicts for FDA Committee Set to Weigh Risks of Seroquel, by Miriam Hill, Philidelphia Enquirer, April 4, 2009.
• Most Psychiatrists Who Wrote Clinical Guidelines Had Financial Ties to Drug Companies, Study Shows, Kaiser Daily Health Policy Report, April 3, 2009.
• Richard Warner's review of Doctors of Deception, Linda Andre's book about electroshock, April, 2009.
• AMA Requests Probe of JAMA Charges, Wall Street Journal, March 28, 2009.
• 3 Researchers at Harvard are Named in Subpoena, by Gardiner Harris, New York Times, March 28, 2009.
• Approval process lowers the number of kids on atypical prescriptions, by Kris Hundley, St. Petersburg Times, March 27, 2009.
• Powerful Proponent of Psychiatric Drugs for Children Primed for a Fall, by Lawrence Diller, San Francisco Gate, March 27, 2009.
• Debate Over Drugs For ADHD Reignites: Long-Term Benefit For Children at Issue, by Shankar Vedantam, Washington Post, March 27, 2009; A01.
• Psychiatric Group Ends Industry-Sponsored Seminars, by Benedict Carey, New York Times, March 26, 2009.
• Kids with ADHD May Learn Better by Fidgeting, by John Cloud, Time Magazine, March 25, 2009.
• Drug Maker Told Studies Would Aid It, Papers Say, by Gardiner Harris, New York Times, March 20, 2009.
  • February 29, 2009, Dr. Joseph Biederman Deposition Transcript.
  • February 27, 2009, Dr. Joseph Biederman Deposition Transcript.
• U doctor scrutinized over drug research: Questions raised after positive review of drug conflicts with maker's, by Jeremy Olson Twin Cities Pioneer Press, March 19, 2009.
• A Silenced Drug Study Creates An Uproar, by Shankar Vedantam, Washington Post,  March 18, 2009.
• Memo to FDA Staff: Don't Leak This, Wall Street Journal, March 17, 2009.
• Seroquel user wants judge to unseal papers for FDA, by Linda A. Johnson, Associated Press, March 11, 2009.
• J&J Unit Marketed Risperdal Off-Label, Ex-Workers Say (Update2), Bloomberg News, March 6, 2009.
• United States Supreme Court March 4, 2009, slip opinion in Wyeth v. Levine, holding state product liability lawsuits over drugs are not pre-empted because the Food and Drug Administration (FDA) has approved the label.
• Prosecutors Plan Crackdown on Doctors Who Accept Kickbacks, by Gardiner Harris, New York Times, March 4, 2009.
• Eli Lilly and the Case for a Corporate Death Penalty, by Bruce E. Levine, AlterNet,  March 3, 2009.
• Exclusive: Sen. Hatch's Secret Drug Firm Links, The Washington Times, March 2, 2009.
• Drug Maker’s E-Mail Released in Seroquel Lawsuit, by Duff Wilson, New York Times, February 28, 2009.
• AstraZeneca Papers Raise Seroquel Issues, by Shirley S. Wang and Avery Johnson, The Wall Street Journal, February 27, 2009.
•  Drug Firm Unseals Papers, by Kris Hundley, Tampa Bay Times, February 27, 2009.
  • Seroquel Documents Unsealed on February 27, 2009. (42 Megabytes)
    • Individual Files
• U.S. Probes Emory Doctor's Glaxo Ties, by David Armstrong, Wall Street Journal, February 26, 2009.
• United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act: Pharmaceutical Company Allegedly Marketed Drugs for Unapproved Pediatric Use and Paid Kickbacks, United States Department of Justice, February 25, 2009.
• Drugmaker Wants to Seal Info -- For you, by Kris Hundley, Tampa Bay Times, February 14, 2009.
• Army Suicides -- Plus ca change, c'est la meme chose, by Grace Jackson, February 10, 2009.
• Abuse is Found at Psychiatric Unit Run by the City, New York Times, February 6, 2009.
  • January 30, 2009, United States Department of Justice Civil Rights of Institutionalized Persons (CRIPA) report, CRIPA Investigation of Kings Country Hospital Center.
• NIDA Study Shows That Methylphenidate (Ritalin) Causes Neuronal Changes in Brain
  Reward Areas: Similarities and Differences Compared to Cocaine were Found, National Institute of Health (NIH), February 2, 2009.
• Good for Business, Bad for Patients? Pfizer's Plan to Buy Rival Wyeth Could Mean ad News for Patients, Physician Says, Opinion by John Abramson, MD, ABC News, January 30, 2009.
• Child Shock Therapy, Australian Herald Sun, January 25, 2009.
• Bitter Pill: Created to treat schizophrenia, Zyprexa wound up being used on misbehaving kids. How the pharmaceutical industry turned a flawed and dangerous drug into a $16 billion bonanza, Rolling Stone, by Ben Wallace-Wells, January 23, 2009.
• Crimes and Confidentiality, by David Egilman, The Pump Handle, January 22, 2009.
• Study Finds Drug Risks with Newer Antipsychotics, by Benedict Carey and Roni Caryn Rabin, New York Times, January 15, 2008.
• Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa $515 Million Criminal Fine Is Largest Individual Corporate Criminal Fine in History; Civil Settlement up to $800 Million, U.S. Department of Justice, January 15, 2009.
  • Criminal Charges Filed Against Eli Lilly, January 15, 2009.
  • Settlement Agreement, January 14, 2009.
  • Guilty Plea, January 15, 2009
• Lilly Said to Be Near $1.4 Billion U.S. Settlement on Drug, by Gardiner Harris, New York Times, January 15, 2009.
• ADHD Medication: Can Your Child Go Without? Behavioral therapy for ADHD—and parent retraining, too—can be good alternatives to medication, by Nancy Shute, U. S. News & World Report, January 14, 2009
• Report of the Office of Inspector General on The Food and Drug Administration's Oversight of Clinical Investigators' Financial Information (January 2009).
• SSRI Pushers Under Fire, by Evelyn Pringle, The Scoop, January 2, 2009.
• Users and Survivors of Psychiatry on the International Stage: A Snapshot, by Peter Lehman, December, 2008.
• State Pharmacist Convicted of Conflict of Interest, by Debra Erdley, Pittsburgh Tribune-Review, December 24, 2008.
• FDA Requires Warnings about Risk of Suicidal Thoughts and Behavior for Antiepileptic Medications, December 16, 2008.
• Get Kids Off Medicine Program is Launched in Metro Area, Louisiana Weekly, December 15, 2008.
• Antidepressants may damage more sex lives, by Carey Goldberg, Boston Globe, December 15, 2008
• 4,000 Kids Under 10 on Mood Drugs, The Australian, December 3, 2008.
• No Reason to Prefer Atypical Antipsychotics of Older Drugs, by John Gever, Senior Editor, MedPage Today, December 4, 2008.
• Official warnings issued: The ADHD drug Strattera CAUSES psychosis, hallucinations, mania and agitation, by Janne Larsson, TransworldNews, December 1, 2008.
• Expert or Shill, New York Times Editorial, November 30, 2008.
• Psychiatric Drugs & Suicide: How Medical Agencies Deceive Patients and Relatives, by Janne Larsson, November, 2008.
• Papers Reveal Push on Drug Firm Funds: Prominent Doctor Tied to Efforts, by Carey Goldberg, Boston Globe, November 25, 2008.
• Research Center Tied to Drug Company, by Gardiner Harris, New York Times, November 24, 2008.
  • Plaintiff's Response in Opposition to Non-Party Joseph Biederman, M.D.'s Motion to Quash and/or Motion for Protective Order, November 12, 2008. (14 megabytes).
• Ailing FDA May Need a Major Overhaul, Officials and Groups Say, by Rob Stein, Washington Post, November 26, 2008.
• Psychiatric Care's Peril and Profits: Lapses at Psychiatric Solutions Inc., a major hospital chain with high earnings, have put patients at risk, regulators find. Some have even died, by Christina Jewett and Robin Fields, Los Angeles Times, November 23, 2008.
• Popular Radio Host Has Drug Company Ties, by Gardiner Harris, New York Times, November 22, 2008.
• Use of Antipsychotics in Children is Criticized, by Gardiner Harris, New York Times, November 19, 2008.
• Foster kids say medication is overprescribed; Legislative Meeting: Youths and graduates of the system offer alternatives, by Lisa Demer, Anchorage Daily News, November 15, 2008.
• The Wholesale Sedation of America's Youth, by Andrew M. Weiss, Skeptical Inquirer, December, 2008, Vol 32:31-36.
• Congressional Report: FDA Career Staff Objected to Agency Preemption Policies, October,2008.
• State medication protocol researchers sought money from drug firms, by Emily Ramshaw, The Dallas Morning News.
• Drugs and Disclosure, New York Times Editorial, October 10, 2008.
• Suit Alleges Pfizer Spun Unfavorable Drug Studies, by Keith Winstein, Wall Street Journal, October 8, 2008.
• Ignored: the mentally ill killed by drugs that are meant to help them: Campaigners plan to use World Mental Health Day to highlight discrimination within the medical profession against some of its most vulnerable patients, by Nina Lakhani, UK Independent, October 5, 2008
• Top Psychiatrist Didn’t Report Drug Makers’ Pay, by Gardiner Harris, New York Times, October 4, 2008
• Doctors told to curb use of Ritalin in hyperactive children Ritalin pills, by Mark Henderson, Science Editor, UK Times, September 24, 2008.
• Senator questions doctors' ties to drug companies, by Emily Ramshaw, The Dallas Morning News, September 24, 2008.
• A Conversation With Nancy C. Andreasen: Using Imaging to Look at Changes in the Brain, by Claudia Dreifus, New York Times, September 16, 2008
• Risks Found for Youths in New Antipsychotics, by Benedict Carey, New York Times, September 15, 2008
• Judge to Unseal Documents on the Eli Lilly Drug Zyprexa, by Mary Williams Walsh, New York Times, September 6, 2008.
• Conflict of interest fears halt children's mental health project, August 18, 2008, by Emily Ramshaw, The Dallas Morning News.
• The incidence and prevalence of diabetes in patients with serious mental illness in North West Wales: Two cohorts, 1875–1924 & 1994–2006 compared, by Joanna Le Noury, Afshan Khan, Margaret Harris, Winnie Wong, Dawn Williams, Tony Roberts, Richard Tranter and David Healy, BioMed Central, August 7, 2008.
• Editorial: The Age of Conflicts—of Interest, by Ronald Pies, MD,Psychiatric Times. Vol. 25 No. 9, August 1, 2008.
  • Credibility Gap, Revisited, by Stefan Kruszewski, M.D., Psychiatric News, August 15, 2008, Vol 43, No. 16:23.
• Suicides & Psychiatric Drugs: A report based on data from The National Board of Health and Welfare in Sweden, by Janne Larsson
• To See or Not to See "Schizophrenia" and the Possibility of Full "Recovery," by John Breeding, Ph.D., Journal of Humanistic Psychology, 2008
• Are Our Leading Pediatricians Drug Industry Shills, by Lawrence Diller, MD, SFGate, July 13, 2008
• Psychiatric Group Faces Scrutiny Over Drug Industry Ties, by Benedict Care and Gardiner Harriss, New York Times, July 12, 2008.
• Doctors Say Medication is Overused in Dementia, New York Times, June 24, 2008.
• Key opinion leaders: independent experts or drug representatives in disguise? by Ray Moynihan, visiting editor, British Medical Journal, June 21, 2008.
• US Investigation Into Glaxo And Paxil Widens, Pharmalot, by Ed Silverman, June 20, 2008.
• Glaxo Attracts Questions Over Data in Paxil Studies: Unsealed Report Claims Suicide Risk Was Miscalculated, by By Alicia Mundy and Jeanne Whalen, Wall Street Journal, June 14, 2008; Page A4.
• Researchers Fail to Reveal Full Drug Pay, by Gardiner Harris & Benedict Carey, New York Times, June 8, 2008.
• America's Medicated Army, Time Magazine, June 5, 2008.
• Medication Effects and the Invisible Wounds of War - Why We Need A Blue Ribbon Panel on Soldier Suicide and Iatrogenic Harm, by Grace E. Jackson, Veterans for Common Sense.
• Irrational Healers, by David Healy, MD, Psychotherapy and Psychosomatics, 77:198-200 (2008)
• Critics say drug firms' payments to doctors are conflict of interest: What they spend: A look at drug company spending in Minnesota — on top specialties and select psychiatrists, by Jeremy Olson and Paul Tosto, Pioneer Press, May 20, 2008.
•  Stealth Marketers: Are doctors shilling for drug companies on public radio? by Shannon Brownlee and Jeanne Lenzer, Slate, May 9, 2008.
• From the American Psychiatric Association Annual Conference, May 9, 2008: Drug Interactions a Common Risk for Schizophrenic Patients.
• To Hell and Back, by Thor Nystom, The University Daily Kansan, May, 2008.
• Studying Placebo Effects Advance the Neuropsychiatric Understanding of Medical Interventions, by Stefan P. Kruszewski, M.D., British Medical Journal, May 7, 2008.
• Eli Lilly's 1st Quarter, 2008, Report on grants.
• Re-focusing upstream: New Drugs, Poorly Recognised Conditions, Genetic Polymorphisms and the Crisis in Mental Health, by Yolande Lucire PhD MB BS DPM FRANZCP (2008).
• "Lethal Drugs Given for Dementia, Times (UK) Online, April 20, 2008.
• Drug Research: To Test or Tout?  Robert Farley, St. Petersburg Times, April 13, 2008.
• One Drug, Two Faces, New York Times, March 25, 2008.
• Lilly Faces Initial Zyprexa Trial: Alaska's Civil Suit Might Set Pattern for Other Actions, by Avery Johnson, Wall Street Journal, February 28, 2008.
• Are Antidepressants Faith-Based Treatment? by  Bruce E. Levine, AlterNe, February 28, 2008.
• Antidepressants: An Untold Story? by Jeanne Lenzer, British Medical Journal, February 27, 2008.
• NJ Legislator: Probe Antipsychotics, Kids & Medicaid, by Ed Silverman, Pharmalot, February 25, 2008.
• Drop in SSRI Prescribing in the United Kingdom Did Not Lead to Youth Suicide Spike, Medscape Medical News, February 21, 2008.
• State (Montana) AG sues two drug companies, by Charles S. Johnson, Helena Independent, State Bureau - 02/22/08
• The Path to Mental Health: Charles Barger Recovered From Illness by Human Connection, by Kathleen Megan, Hartford Courant, February 17, 2008.
• Psychiatrists, Children and Drug Industry’s Role, by Gardiner Harris, Benedict Carey and Janet Roberts, New York Times, May 10, 2007.
• Fox, Big Story w Doug Kennedy on NIU shooter/antidepressants, February 15, 2008.
• Unsealed (except 9 pages) Joseph Glenmullen, MD, analysis of Paxil suicidality kept hidden by GlaxoSmithKline.
• Did GSK trial data mask Paxil suicide risk? Science, February, 2008.
• Lilly in Talks With US, by Alex Berenson, New York Times, January 30, 2008 (Web Version).
• Lilly Considers $1 Billion Fine to Settle Case, by Alex Berenson, New York Times, January 31, 2008.
• No Significant Association of 14 Candidate Genes With Schizophrenia in a Large European Ancestry Sample: Implications for Psychiatric Genetics, by Alan R. Sanders, M.D., Jubao Duan, Ph.D., Douglas F. Levinson, M.D., Jianxin Shi, Ph.D., Deli He, B.S., Cuiping Hou, B.S., Gregory J. Burrell, B.S., John P. Rice, Ph.D., Deborah A. Nertney, B.S., Ann Olincy, M.D., Pablo Rozic, M.D., Sophia Vinogradov, M.D., Nancy G. Buccola, A.P.R.N.B.C., Bryan J. Mowry, M.D., Robert Freedman, M.D., Farooq Amin, M.D., Donald W. Black, M.D., Jeremy M. Silverman, Ph.D., William F. Byerley, M.D., Raymond R. Crowe, M.D., C. Robert Cloninger, M.D., Maria Martinez, Ph.D., and Pablo V. Gejman, M.D., American Journal of Psychiatry, AiA:1–10.
• Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy, by Erick H. Turner, M.D., Annette M. Matthews, M.D., Eftihia Linardatos, B.S., Robert A. Tell, L.C.S.W., and Robert Rosenthal, Ph.D, New England Journal of Medicine, 358;3 (January 2008).  This study found that 37 of 38 trials that the F.D.A. viewed as having positive results were published in journals, but only 14 of the 36 studies the FDA viewed as failed or unconvincing made it into journals and 11 of those “conveyed a positive outcome” that was not justified by the underlying F.D.A. review.
• Florida undecided as states sue over costly drug program, Daytona Journal, January 10, 2008.
• The ADHD drug Strattera – actions needed now, Open Letter to the UK's Medicines and Healthcare products Regulatory Agency (MHRA) by Jan Larsson.
• Forced Drugging of Children in Foster Care: Turning Child Abuse Victims into Involuntary Psychiatric Patients, by M. McKay, Ph.D., JOM, Vol. 22, No. 2 (2007).
• Rethinking Social Recovery in Schizophrenia: What a Capabilities Approach Might Offer, by Kim Hopper, Social Science & Medicine 65 (2007) 868-879.
• Some fear medicines may put foster kids' future health at risk, by Gary Craig, Rochester Democrat and Chronicle, December 10, 200.
• Drugs for ADHD "Not the Answer," BBC, November 12, 2007.
• Danger drugs designed for schizophrenics used to calm children, by Fiona MaCrae, Daily Mail, September 11, 2007.
• Pediatric bipolar disorder: An object of study in the creation of an illness, by David Healy and Joanna Le Noury, International Journal of Risk & Safety in Medicine, 19 (2007) 209–221.
• Senator Grassley seeks thorough review of nursing home use of anti-psychotic drugs, December 6, 2007.
• FDA Science and Mission at Risk Report of the Subcommittee on Science and Technology, prepared for the FDA by the FDA Science Board, November 2007.  This formerly confidential report's three main conclusions are: (1) The FDA cannot fulfill its mission because its scientific base has eroded and its scientific organizational structure is weak, (2) The FDA cannot fulfill its mission because its scientific workforce does not have sufficient capacity and capability, and (3) The FDA cannot fulfill its mission because its information technology (IT) infrastructure is inadequate.
• The Media and the Chemical Imbalance Theory of Depression, by Jonathan Leo & Jeffrey R. Lacasse, Springer Science, (2007)
• Corporate Funding and Conflicts of Interest: A Primer for Psychologists, by Wendy S. Pachter Washington, Ronald E. Fox Human, Philip Zimbardo, and David O. Antonuccio, American Psychologist (December 2007).
• Some fear medicines may put foster kids' future health at risk, by Gary Craig, Rochester Democrat and Chronicle, December 10, 2007.
• Potent Pills: More foster kids getting mood-altering drugs, by Gary Craig, Rochester Democrat and Chronicle, December, 9, 2007.
• Prescription Abuse Seen In U.S. Nursing Homes: Powerful Antipsychotics Used to Subdue Elderly; Huge Medicaid Expense, by Lucette Lagnado, Wall Street Journal, December 4, 2007, A1.
• The Media and the Chemical Imbalance Theory of Depression, by Jonathan Leo & Jeffrey R. Lacasse, Society, 2007.
• Complaint in Arkansas v. Janssen Pharmaceutical Co. for Medicaid Fraud and other claims, filed November 20, 2007.
• Drugs for ADHD "Not the Answer," BBC, November 12, 2007.
• Psychiatry: 60 years in an increasingly corrupt specialty, an interview with psychiatrist Nathaniel Lehrman, November 11, 2007.
• Forced Drugging of Children in Foster Care: Turning Child Abuse Victims into Involuntary Psychiatric Patients, by M. McKay, Ph.D., Journal of Orthomolecular Medicine, Vol. 22, No. 2, 2007
• Danger drugs designed for schizophrenics used to calm children, by Fiona MaCrae, Daily Mail, September 11, 2007.
• World Experts Demand End to Child Drugging in the US - Part II, by Evelyn Pringle, Lawyers & Settlements, October 27, 2007.
• World Experts Demand End to Child Drugging in the US - Part I, by Evelyn Pringle, Lawyers & Settlements, October 27, 2007.
• A Systematic Review of Mortality in Schizophrenia: Is the Differential Mortality Gap Worsening Over Time? by Sukanta Saha, MSc, MCN; David Chant, PhD; John McGrath, MD, PhD, Arch Gen Psychiatry, 2007;64(10):1123-1131.
• From Sweden--Reported suicides – more than 80 percent got psychiatric drugs, well over 50 percent got antidepressants, TransWorld News, October 7, 2007.
• Forced Drugging of Children in Foster Care: Turning Child Abuse Victims into Involuntary Psychiatric Patients, by M. McKay, Ph.D., JOM, Vol. 22, No. 2 (2007).
• Lilly Adds Label Warnings for Mental Drug Zyprexa, by Alex Berenson, New York Times, October 5, 2007
• Arkansas Plans Lawsuit Over Antipsychotics, Pharmalot, September 23rd, 2007, by Ed Silverman
• Worse Than Vioxx: Zyprexa, Risperdal, Clozaril, And Paxil Killed Thousands Of Americans, by Philip Dawdy, Furious Seasons, September 19, 2007.
• The Truth is Not Free, by David Egilman, MD, the doctor from who Jim Gottstein subpoenaed the Zyprexa Papers, about his recent settlement with Eli Lilly (Stipulation and Order, Affidavit), in Sequestered Science, September 11, 2007.
• Psychiatrists' Failure to Inform: Is There Substantial Financial Exposure?, by James B. Gottstein, Esq., Ethical Human Psychology and Psychiatry, Vol 9, No. 2, 117-125 (2007).
• Attorney Subpoenas J&J, AstraZeneca and Lilly for Hidden Antipsychotic Data Part I, Evelyn Pringle, September 10, 2007, Lawyers and Settlements."
• Authorities baffled at baby anti-depressant prescriptions, September 10, 2007, StuffCo.NZ.
• Sidelining Safety — The FDA's Inadequate Response to the IOM, by Sheila Weiss Smith, Ph.D., New England Journal of Medicine, 357:960-963 September 6, 2007, Number 10.
• Biological Psychiatry: A Practice in Search of a Science, by W. Joseph Wyatt & Donna M. Midkiff, Behavior and Social Issues, 15, 132-151 (2006).
• The Future of Drug Safety: Action Steps by Congress, by the Institute of Medicine, September, 2006.
• American Kids Being Drugged To Death, by Evelyn Pringle.
• Psychotropic Drug Makers Bankroll Prescribing Shrinks Part II,  Evelyn Pringle, September 2, 2007, Lawyers and Settlements."
• Psychotropic Drug Makers Bankroll Prescribing Shrinks Part I,  Evelyn Pringle, August 30, 2007, Lawyers and Settlements.", Evelyn Pringle, Lawyers & Settlements, August 22, 2007.
• The Lives they Left Behind: Suitcases Cases from a State Hospital Attic, from  Darby Penney and Peter Stastny.
• Doctor, just a little something for you: Complex sales strategies go way beyond freebies, by By Melissa Healy, Los Angeles Times Staff Writer, August 6, 2007
  • Selling the Patient: Next step: Create the demand; Direct, emotional ads for prescription drugs are everywhere. But they're just one way to get to the consumer, by By Melissa Healy, Los Angeles Times Staff Writer
• The Right Rx for Sadness: Drugs may be an easy choice but not a good one, by By Deborah Kotz, US News & World Report,  7/29/07
• Ped Med: Kid use of mind medicines rising, by Lidia Wasowicz, UPI Senior Science Writer, July 10, 2007.
• Psychiatrists Top List in Drug Maker Gifts, by Gardiner Harris, New York Times, June 27, 2007.
• No MedGuide for Zyprexa after Eleven Years of Death and Injury, by Evelyn Pringle, Op Ed News, June 18, 2007.
• Backlash on bipolar diagnoses in children: MGH psychiatrist's work stirs debate, by Scott Allen Boston Globe, June 17, 2007.
• After Sanctions, Doctors Get Drug Company Pay, by Gardiner Harris and Janet Roberts, New York Times, June 3, 2007
• Drugs Might Breed Violence, Tacoma News Tribune, May 28, 2007.
• Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising, by Dominick Frosch et. al., Annals of Family Medicine, January/February 2007.
•  Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs, by Peter R. Breggin, MD, Ethical Human Psychology and Psychiatry, Volume 8, Number 3, Fall/Winter 2006.
• New World New Dangers (Zyprexa Papers), by Joshua Slatko, Med Ad News, May 2006.
• Is there a fox in the Medicaid henhouse? Anne Stanton, Northern Exposure.
• Is our pill-popping society losing its mind? Anne Stanton, Northern Exposure
• Psych meds drove my son crazy, Salon, May, 2007.
• Psychotic Reactions And Medicaid: One Man's Quest To Learn The Truth: Meet Ben Hansen, by Ed Silverman, Pharmalot, May 17, 2007.
• Are kids being overdosed?, Northern Express, May 2007.
• Doctors Fail to Recognize Life-Threatening Serotonin Syndrome, by Evelyn Pringle, Op Ed News, May 4, 2007.
• New York Times, Psychiatrists, Children and the Drug Industry's Role, May 10, 2007.
• United States Senate Finance Committee Staff Report on Use of Educational Grants by Pharmaceutical Companies, April, 2007.
• Zyprexa Hole Gets Deeper, by Evelyn Pringle, Lawyers & Settlements, May 1, 2007.
• Following the Script: How Drug Reps Make Friends and Influence Doctors, by Adriane Fugh-Berman and Shahram Ahari, PLoS Medicine, Vol. 4, No. 4, 621-5 (April 2007).
• A National Survey of Physician–Industry Relationships, by Eric G. Campbell, Ph.D., Russell L. Gruen, M.D., Ph.D., James Mountford, M.D., Lawrence G. Miller, M.D., Paul D. Cleary, Ph.D., and David Blumenthal, M.D., M.P.P., New England Journal of Medicine, 356;17, 1742-1750 (2007) 
• Lilly Receives Zyprexa Greetings From Capitol Hill, by Evelyn Pringle, April 27, 2007.
• New York Times, U.S. Wonders if Drug Data Was Accurate, by Alex Berenson, April 25, 2007.
• DSM and the Death of Phenomenology in America: An Example of Unintended Consequences, by Nancy C. Andreasen, Schizophrenia Bulletin vol. 33 no. 1 pp. 108–112, 2007
• Patients Diagnosed Schizophrenic and Bipolar To Boost Seroquel Sales, by Evelyn Pringle, April 11, 2007.
• Senator Grassley asks for Zyprexa Papers and other documents, April 4, 2007.
• In Some States, Maker Oversees Use of Its Drug, by Stephanie Saul, New York Times, March 23, 2007.
• Popular Zyprexa linked to illnesses: Schizophrenia drug at center of lawsuit, The Plain Dealer, March 17, 2007.
• Lilly Fraudulently Marketed Zyprexa, Montana Claims, by Margaret Cronin Fisk, Bloomberg News, March 12, 2007.
• Makers of Zyprexa Risperdal and Seroquel Under Fire, by Evelyn Pringle, March 9, 2007.
• Why Clients Should Not Take Psychotherapists into Their Confidence, by Jim Gottstein, ISPS-US Newsletter: Winter, 2006/2007, Volume 7, Issue 3.
• Does compulsory or supervised community treatment reduce 'revolving door' care? Legislation is inconsistent with recent evidence, by Stephen Kisely and Leslie Anne Campbell, British Journal of Psychiatry, 197, 373-374 (2007)
• A Mix of Medicines That Can Be Lethal, by Jane Brody, New York Times, February 27, 2007.
• Taking back the FDA, by Marcia Angell, Boston Globe, February 26, 2007
• Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa, by Evelyn Pringle, Op Ed News, February 26, 2007.
• Off-Label Sales of SSRIs Leads To More Litigation, by Evelyn Pringle, Op Ed News, February 22, 2007.
• Debate Over Children and Psychiatric Drugs, by Benedict Carey, New York Times, February 15, 2007.
• February 14, 2007, New York Times, Judge Rules Drug Documents Must Be Returned to Eli Lilly, by Landon Thomas, Jr.
• February 8, 2007, Secrecy's dangerous side effects: When legal settlements allow companies to hide their mistakes, what we don't know can hurt us, by Richard Zitrin
• February 5, 2007, Nobody Buys Lilly's Innocence Routine About Zyprexa, by Evelyn Pringle
• February 1, 2007, Zyprexa Injury Clock Keeps Ticking Away, by Evelyn Pringle.
• January 25, 2007, Eli Lilly The Habitual Offender, by Evelyn Pringle.
• Comment: The Role of Litigation in Defining Drug Risks, by Aaron S. Kesselheim, MD, JD and Jerry Avorn, MD, Journal of American Medical Association (JAMA), JAMA, January 17, 2007—Vol 297, No. 3; 308-311.
• Neuroleptics – Effects, Risks, Education and Treatment Contexts, by Volkmar Aderhold, presented at Institute for Social Psychiatry at the University of Greifwald, 01/2007
• States Study Marketing of Lilly Pill, by Alex Berenson, New York Times, January 20, 2007.
• Evidence Lacking To Support Many Off-Label Uses Of Atypical Antipsychotics, Medical News Today, January 18, 2007.
• Attorney Asks Eli Lilly to Issue Warning on Zyprexa, by By Evelyn Pringle, Op Ed News, January 14, 2007
• Public Has Right To Know Secrets Revealed In Zyprexa Documents, by Evelyn Pringle, Op Ed News, January 12, 2007
• New York Times, Lilly to Pay Up to $500 Million to Settle Claims, by Alex Berenson, January 4, 2007.
• New York Times, Mother Wonders if Psychosis Drug Helped Kill Son, by Alex Berenson, January 4, 2007.
• PsychRights writes Eli Lilly on December 27, 2006, requesting it send a "Dear Doctor" letter to all health care professions "advising them Zyprexa should not be prescribed to anyone who is not already taking it.
• Video of former Eli Lilly drug rep talking about how they were instructed to downplay Zyprexa's negative effects.
• Court Allows Eli Lilly To Bury Zyprexa Documents, by Evelyn Pringle, Op Ed News, December 21, 2006.
• New York Times, Disparity Emerges in Lilly Data on Schizophrenia Drug, by Alex Berenson, December 21, 2006.
• New York Times, Court Orders Lawyer to Return Documents About an Eli Lilly Drug, December 20, 2006.
• New York Times Editorial, Playing Down the Risks of a Drug: Internal documents offer persuasive evidence that Eli Lilly engaged in questionable behavior to prop up its best-selling drug, December 19, 2006. New York Times, Drug Files Show Maker Promoted Unapproved Use, December 18, 2006.
• New York Times, Eli Lilly Said to Play Down Risk of Top Pill, December 17, 2006. 
• Ann Blake Tracy, Ph.D's December 13, 2006 and and September 13, 2004 FDA testimony on SSRI anti-depressants.
• Forced Drugging and Special Services: A Holocaust in America’s Schools, by Dr. Salvatore Pizzuro, Disability Policy Specialist
• NY TImes, Proof Is Scant on Psychiatric Drug Mix for Young, by Gardiner Harris, November 23, 2006.
• Morbidity and Mortality in People with Serious Mental Illness, by National Association of State Mental Health Program Directors, October 2006.  This study found that the rate of serious morbidity (illness) and mortality (death) of people diagnosed with serious mental illness has accelerated to the point where they are now dying 25 years earlier than the general population.  The Executive Summary does not attribute this to psychiatric drugs, but the body of the report is pretty clear that the major change is the advent of the second generation neuroleptics, also misnomered "atypical antipsychchotics" and the great increase in polypharmacy, the practice of giving multiple psychiatric drugs to patients.
• Biological Psychiatry: A Practice in Search of a Science, by W. Joseph Wyatt & Donna M. Midkiff, Behavior and Social Issues, 15, 132-151 (2006).
• What’s Wrong With a Child? Psychiatrists Often Disagree, New York Times, November 11, 2006.
• The Other Side of Psychopharmacology: A Review of the Literature, by Thomas L. Murray, Jr., Journal of Mental Health Counseling, Volume 28/Number 4/October 2006/Pages 309–337
• Report on Multi-Faceted Grass-Roots Efforts To Bring About Meaningful Change To Alaska's Mental Health Program 
• The Other Youth Drug Problem, Alternative Medicine, December, 2006.
• Soteria – a treatment model and a reform movement in psychiatry, by Volkmar Aderhold - Translated by Peter Stastny - September 2006, In honour of Loren Mosher.
• Uphill Battle-Warning Pharma Customers About Dangers of SSRIs
• Drug Interactions Financial Ties to Industry Cloud Major Depression Study, Wall Street Journal, July 11, 2006.
• Antipsychotic Prescriptions Rise Sharply for Children and Adolescents, National Institute of Mental Health, June 2006.
• Commercial bias in medical journals: Commercial influence and the content of medical journals, by Joel Lexchin, Donald W Light, British Medical Journal, 2006; 332:1444-7.
• Congruencies in Increased Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public Mental Health Clients in Eight States. by Craig W. Colton, PhD, Ronald W. Manderscheid, PhD, Preventing Chronic Disease, Volume 3: No. 2, April 2006.  This study found deceased public mental health clients had died at much younger ages and lost decades of potential life when compared with their living cohorts nationwide. Clients with major mental illness diagnoses died at younger ages and lost more years of life than people with non-major mental illness diagnoses.
• BBC July 1, 2006, article on Clozapine, Schizophrenia drug 'health risk'.
• In Diabetes, One More Burden for the Mentally Ill, New York Times, June 12, 2006.
• The Plan to Drug America's School Children: The President’s New Freedom Commission On Mental Health, by George Stone, MA, MSW
• Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem, by Joanna Moncrieff, Medical Hypothesis, 2006.
• Outrage! Preschoolers used as guinea pigs in psychotropic drug tests, by Mike Adams, Natural News, May 18, 2006.
• Open Letter to Sally Satel from Michael Allen, Senior Staff Attorney, Bazelon Center for Mental Health Law, May 5, 2006.
• Comparison of Schizophrenia Drugs Often Favors Firm Funding Study, Washington Post, Wednesday, April 12, 2006
• ADHD, Drug Labels, and the FDA: The Continuing Pre-Emption of Public Health, by Grace E. Jackson, MD., March 28, 2006
• FDA Urges Stronger Warnings on ADHD Drugs, Wall Street Journal, March 15, 2006.
• Special Report: Court Filing Makes Public My Previously Suppressed Analysis of Paxil’s Effects, by Peter R. Breggin, MD, Ethical Human Psychology and Psychiatry, Volume 8, Number 1, Spring 2006, 77-84.
  • Full Report (sworn written testimony filed in the Lacuzong Case).
• Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared, by D. Healy, M. Harris, R. Tranter, P. Gutting, R. Austin, G. Jones-Edwards and A.P. Roberts, British Journal of Psychiatry (2006), 188, 223-228.  This study documents how the suicide rate went from one half of one percent before the advent of neuroleptics (and deinstitutionalization) to four percent in the modern era where neuroleptics are the standard treatment.
• The Gaithersburg Address: ADHD Medications: Risks and Benefits, Sue Parry's Testimony to the FDA, February 9, 2006.
•  The latest mania: Selling bipolar disorder, by D. Healy, PLoS Med 3(4): e185 (2006).
• The Under Reported Story: ADHD, Stimulants, and the FDA, by Grace E. Jackson, MD, February 18, 2006.
• Associated Press, February 10, 2006: FDA Panel recommends "Black Box" warning regarding lethal potential of ADHC Drugs (Ritalin, etc.).
• Trends in Prescribing of Antipsychotic Medications for US Children, by William O. Cooper, MD, MPH; Patrick G. Arbogast, PhD; Hua Ding, MS; Gerald B. Hickson, MD; D. Catherine Fuchs, MD; Wayne A. Ray, PhD, Ambulatory Pediatrics, 2006;6:79–83, documents the astonishing increase in prescriptions of neuroleptics to children.
• FDA Urges Stronger Warnings on ADHD Drugs, Wall Street Journal, March 15, 2006.
• Stimulant Treatment of ADD/ADHD: Concerns about Adverse Effects, DuBose Ravenel, M.D., F.A.A.P., written testimony to FDA for March 22, 2006 Pediatric Committee Meeting.
• The Australian: Dark side of a wonder drug, March 28, 2006.
• The Age (Australia): Children on ADHD drugs suffer strokes, March 27, 2006.
• ADHD: The new stimulant threat, An estimated six million of our children are taking powerful prescription amphetamines known to speed freaks as the champagne of uppers.
• Attention Surplus? Re-examining a Disorder, by Paul Steinberg, MD, New York Times, March 7, 2006.
• Disposition of Emergency Department Visits for Drug-Related Suicide Attempts by Adolescents: 2004, February, 2006, by the Drug Abuse Warning Network (DAWN),  in Office of Applied Studies (OAS), Substance Abuse and Mental Health Services Administration (SAMHSA).  This review of emergency room visits found that over 40% of the over 15,000 adolescent suicide attempts resulting in emergency room visits in 2004 involved psychiatric drugs.
• Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm? by John R. Bola, Schizophrenia Bulletin vol. 32 no. 2 pp. 288–296, 2006, doi:10.1093/schbul/sbj019.
• The Under Reported Story: ADHD, Stimulants, and the FDA, by Grace E. Jackson, MD, February 18, 2006.
• Associated Press, February 10, 2006: FDA Panel recommends "Black Box" warning regarding lethal potential of ADHC Drugs (Ritalin, etc.).
• Pediatric bipolar disorder: An object of study in the creation of an illness, by David Healy and Joanna Le Noury, International Journal of Risk & Safety in Medicine, 19 (2007) 209–221.
• Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits, by Jennifer Glass, Krista L Lanctôt, Nathan Herrmann, Beth A Sproule, Usoa E Busto, British Medical Journal, BMJ, doi:10.1136/bmj.38623.768588.47 (published 11 November 2005).
• Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications, ACTA Psychiatrica Scandinavica,  2005: 112: 330–350
• Zyprexa IM Caution Issued in Some Countries But Not U.S, by Mark Moran, Psychiatric News, April 15, 2005, Vol. 40 No. 8.
• Consumer Advertising of Psychiatric Medications Bias Public Against Non-pharmocological Treatment,  by Jeffrey R. Lacasse, Ethical Human Psychology and Psychiatry, Vol. 7, No. 3, Fall/Winter 2005.
• Mental Illness and the Freedom to Refuse Treatment: Privilege or Right, by Ron Bassman, Professional Psychology: Research and Practice, 2005, Vol 36, No. 5, 488-497.
• Confidential Master Settlement Agreement in Zyprexa I,  filed with the Securities and Exchange Commission, November 3, 2005.
• Trouble in Prozac Nation, Fortune Magazine, November 2005.
• Bitter Pills: They're prescribed to millions, but do the new antidepressants work? And are they worth the risk? Time Magazine, Asia Edition, November 14, 2005.
  • Taking on Drug Defenders.
• How the Legal System Can Help Create a Recovery Culture in Mental Health Systems,
• New Drugs, New Problems, by Dr. Yolande Lucire, Australian Journal of Forensic Sciences, 37:1, in Press as of November 6, 2005.
• Rethinking schizophrenia: its original nature, its drug-altered character, and thoughts about its treatment, by Nathaniel S. Lehrman, M.D., presented at the International Center for the Study of Psychiatry and Psychology (ICSPP) October, 2005, Conference.
• Drug Secrets: What the FDA isn't telling, Slate, September 27, 2005, by Jeanne Lenzer.
• GPs to stop prescribing antidepressants blamed for suicidal feelings in under-18s, The Guardian (UK), September 28, 2005.
• Little Difference Found in Schizophrenia Drugs, The New York Times, and Generic Fares Well In Big Psychiatry Study: Newer, Costlier Drugs Have Little Advantage for Schizophrenia;Comparative Data on Side Effects in the Wall Street Journal September 20, 2005, discuss the just released study from the New England Journal of Medicine, Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia, demonstrating little if any more benefit or fewer problems with the so-called "atypical" neuroleptics, such as Zyprexa, Risperdal, Geodon, and Seroquel that cost so much more over the older ones, such as Thorazine, Haldol, Prolixin and Navane.
• First trimester antidepressant risk, from Australian Dr., describes SSRIs doubling the risk of birth defects if used during pregnancy.
• New Antipsychotic Drugs Worrying, new study shows, Globe and Mail, September 13, 2005.
• Are ADHD drugs safe? Report finds little proof, Tacoma Tribune, September 13th, 2005, reports the most comprehensive scientific analysis of the drugs to date has found little evidence that they are safe, that one drug is more effective than another or that they help school performance.
• Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America, by Robert Whitaker, Ethical Human Psychology and Psychiatry, Volume 7, Number I: 23-35 Spring 2005.
• My Whole Body is Sick . . . My Life is Not Good:  A Rwandan asylum seeker attends a psychiatric clinic in London, by Derek Summerfield, Ch. 6 from: Forced Migration and Mental Health. Rethinking the Care of Refugees and Displaced Persons (ed D. Ingleby) New York: Springer 2005.
• Top-selling drug (Seroxat/Paxil) linked to increased suicide risk, London Times, August 22, 2005.
• Bay Area Street Smart's August, 2005 series on psychiatric abuses.
  • Homelessness and Psychiatric Abuse
  • Toxic Psychiatric Drugs: Interview with Robert Whitaker
  • Electroshock Must Be Banned
  • Zyprexa: A Prescription for Disease & Death
  • The Dangers of Antidepressants
  • Mental Health Policy: Humane or Reactionary?
• Officials Bicker as Mentally Ill Wither, Los Angeles Times, August 3, 2005.
• Context and Cooperation in Strategic Therapy: Toward a Contextual Mental Health (Draft Copy July 28, 2005) by
  George Stone, MA, MSW.
• Huge Mental Health Victory for MN Families: MN parents & children protected from mental health coercion & universal screening, Edwatch, July 18, 2005
• How to Quit the Cure, Newsweek, August 8, 2005.
• Death of the Magic Bullet, Sunday (London) Times, July 31, 2005.
• Bitter Pill, in Columbia Journalism Review, August 2005, describes the Media's contributing role to false and misleading information about the safety and benefits of new drugs.
• A Curious Consensus: “Brain Scans Prove Disease?” By Grace E. Jackson, MD, July 10, 2005 (Revised Sept. 2005)
• Stefan P Kruszewski: Schizophrenia and Epilepsy: Untenable Link from Flawed Research Design  (5 July 2005)  responding to Ping Qin, Huilan Xu, Thomas Munk Laursen, Mogens Vestergaard, and Preben Bo Mortensen, Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study BMJ 2005; 331: 23.
• Three Part Washington Post Series by Shankar Vedantam on Mind and Culture: Psychiatry's Missing Diagnosis
  • Patients' Diversity Is Often Discounted, June 26, 2005.
  • Social Network's Healing Power Is Borne Out in Poorer Nations, June 27, 2005.
  • Racial Disparities Found in Pinpointing Mental Illness, Tuesday, June 28, 2005.
• June 1, 2005, Freedom of Information Act transmittal of Adverse Reactions to Olanzapine (Zyprexa).  (13 MB)
• The Marketization of Depression: Prescribing SSRI Antidepressants to Women, by Janet Currie, Women and Health Protection, May 2005.
• House of Commons Health Committee: The Influence of the Pharmaceutical Industry, March 22, 2005.
• What Can We Learn from Medical Whistleblowers? Their experiences paint a troubling picture of American medicine's ties with the pharmaceutical industry, by Jeanne Lenzer in the Public Library of Science (PLOS), May 27, 2005, Volume 2, Issue 7.
  • Why PLoS Sponsored a Roundtable of Medical Whistleblowers
• The Ethics of Electroconvulsive Therapy (ECT) by Loren R. Mosher MD and David Cohen, PhD, Journal of the American Medical Association October 2003, Volume 5, Number 10
• The Influence of Big Pharma: Wide Ranging Report Identifies Many Areas of Influence and Distortion, British Medical Journal, April 16, 2005,  BMJ 2005;330:857–8
• Opportunity cost of antidepressant prescribing in England: analysis of routine data, by Sandra Hollinghurst, David Kessler, Tim J Peters, David Gunnell, British Medical Journal (BMJ), BMJ, doi:10.1136/bmj.38377.715799.F7 (published 18 March 2005)
• In its February 19, 2005, issue, the British Medical Journal (BMJ) published three articles about SSRI Antidepressants and suicide.
  • Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
  • Suicide, Depression and Antidepressants: Patients and Clinicians Need to Balance Benefits and Harms
  • Pills, Thrills and Bellyaches (Editorial)
• Randomized Controlled Trials: Evidence Biased Psychiatry, By David Healy, MD MRCPsych
• An Examination of Eli Lilly and Company's Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance, by Dr. Peter Breggin, January 12, 2005.
• Dr. Grace Jackson's June 6, 2004 Public Lecture, "What Doctors May Not Tell You About Psychiatric Drugs," to the UCE Centre for Community Mental Health, in Birmingham, England.
• California Court bans electroshock at Santa Barbara College Hospital on January 5, 2005 in Akkerman v. Johnson.
• PsychRights 2004 Year-End Report.
• FDA Scientists Issued Early Warnings on Drug Approvals: Staff Survey Echoes Safety Concerns Raised by Dr. Graham in Senate
• In Re: Robert S, November 18, 2004, Illinois Supreme Court Opinion holding the State of Illinois violated Robert's constitutional rights, as a pretrial detainee in a forced medication proceeding based on his purported best interests, by not notifying his criminal defense attorney and failing to appoint a psychiatrist as an independent expert witness, rather than a psychologist.
• PsychRights Joins MindFreedom Shield Program
  • Advance Directives at PsychRights
• National Mental Health Screening of children effort likely  to be orchestrated by drug companies to increase percentage of kids on psychiatric drugs.
  • Form letter invoking right to prevent screening under the Protection of Pupil Rights Amendment (PPRA).
  • Send a Message to Congress Opposing Funding for Screening
  • Bush Wants to Screen All Children for Mental Illness, by Keith Hoeller, Ph.D., September 19, 2004, editor of Review of Existential Psychology & Psychiatry.
  • On November 12, 2004, Jim Gottstein of the Law Offices of James B. Gottstein wrote a letter to  Ted Stevens, chair of the Senate Appropriations Committee regarding funding for screening.
• Mental Health "Parity": Why Waste Money, Endanger Civil Liberties? Special to The Seattle Times, Thursday, February 10, 2005, By Keith Hoeller
• Ontario Electroshock ("ECT") Statistics 2000-2002 (third draft), compiled by Don Weitz.
• International Consensus: ADHD and Abuse in the Prescription of Psychopharmaceutical Drugs to Minors (January 2005) "Giu' Le Mani Dai Bambini®" National Campaign for the Defence of Children's Right to Health.
• Drug firms lagging on openness: Despite vow, few studies publicized, Boston Globe,  January 9, 2005.
• The Prozac Paradox: Why antidepressants may exacerbate depression and anxiety in some kids and teens, Popular Science, January 2005.
• The Dictionary of Disorder, by Alix Spiegel: How one man revolutionized psychiatry, The New Yorker, January 3, 2005, posted December 27, 2004.
• FDA to Review "Missing" Drug Company Documents, British Medical Journal, December 31, 2004, BMJ VOLUME 330 1 JANUARY 2005 bmj.com.
  • Copy of the 1988 Document publicly released January 4, 2005.  (7 MB)
  • Dispute Puts a Medical Journal Under Fire, New York TImes, January 17, 2005.
• FDA Scientists Issued Early Warnings on Drug Approvals: Staff Survey Echoes Safety Concerns Raised by Dr. Graham in Senate Testimony, Union of Concerned Scientists, December, 2004.
• Dr. Joseph Glenmullen's Q&A from ABC News on Anti-Depressants.
• At F.D.A., Strong Drug Ties and Less Monitoring, New York Times, December 6, 2004.
• Scientific American Mind, December 2004 Issue, Treating Depression: Pills or Talk?
• Crisis deepens at the US Food and Drug Administration, British Medical Journal, December 4, 2004, BMJ 2004;329:1308 (4 December), doi:10.1136/bmj.329.7478.1308
• Contracts Keep Drug Research Out of Reach, New York Times, November 29, 2004.
• Public interest group accuses FDA of trying to discredit whistleblower, British Medical Journal, November 27, 2004
• Forbes: Antidepressants Tied to Abnormal Bleeding
• Minutes of Evidence, United Kingdom Parliament, House of Commons, Select Committee on Health, October 14, 2004.
  • David Healy, MD Memorandum
  • David Healy, MD, Statement of Competing Interests
  • Manufacturing Consensus, by David Healy MD FRCPsych. In Press in Greenslit, N (Ed). Pharmaceutical Cultures: Marketing Drugs and Changing Lives in the US Rutgers University Press as found on the United Kingdom Parliament website.
• New York Times Magazing, November 21, 2004, The Antidepressant Dilemma.
• Stun gun deaths raise drug-link questions, Sacramento Bee, November 13, 2004
• Bush's plan to screen for mental health meets opposition in Illinois, British Medical Journal, November 6, 2004.
• Biomedical Bias of the American Psychiatric Association, by Duncan B. Double, MA, MRCPsych.  This is an academic article that deconstructs the American Psychiatric Association's September, 2003 "Statement" responding to the Fast for Freedom in Mental Health.
• Psychiatric Fraud and Force: A Critique of E. Fuller Torrey, by Thomas Szasz, M.D., 416 Journal of Humanistic Psychology, Vol. 44 No. 4, Fall 2004 416-430.
• 2004 letter responding to assertions that (1) ADHD is generally considered to be a neurochemical disorder, (2) ADHD is present from birth, and (3)
  ADHD is not caused by poor parenting, dysfunctional families, poor schooling or nutrition.
• Did major media outlets fail to ask the right questions about depression study? British Medical Journal, September 25, 2004.
• Seroxat (Paxil) and Prozac 'can make people homicidal,' The Guardian, September 21, 2004.
• Bush Wants to Screen All Children for Mental Illness, by Keith Hoeller, Ph.D., September 19, 2004, editor of Review of Existential Psychology & Psychiatry.
• Presentation before the FDA on September 13, 2004, Lawrence Diller, M.D.
• FDA Urged Withholding Data on Antidepressants Makers Were Dissuaded From Labeling Drugs as Ineffective in Children, Washington Post, Friday, September 10, 2004.
• A Commentary on the Proposal to Observe the Effects Of a Single Dose of Amphetamine in Children, by Jonathan Leo, Ph.D., Submitted for the Food and Drug Administration’s Meeting of the Pediatrics Ethics Subcommittee of the Pediatric Advisory Committee on September 10, 2004.
• Journals Insist Drug Manufacturers Register All Trials, in the Washington Post, September 8, 2004
• GlaxoSmithKline Settles NY Fraud Suit, promising to disclose all drug trial results, August 26, 2004.  See, Consent Decree (Settlement) and Press Release.
• Prozac Nation: Is the Party Over? By Richard C. Morais,  Forbes, August 20, 2004.
• Bush plans to screen whole US population for mental illness, Jeanne Lenzer New York British Medical Journal, Vol. 328, 19 June 2004, page 1458, bmj.com (PDF Version).
• Secret US report surfaces on antidepressants in children, by Jeanne Lenzer New York, British Medical Journal, Vol.329 7 AUGUST 2004, page 307 bmj.com.
• Janssen, July 21, 2004 "Dear Health Care Provider" Letter for Risperidone (Risperdal).
  • April 19, 2004, FDA Warning Letter to Janssen about its previous Dear Health Care Provider being "false or misleading," which resulted in the July 21, 2004  letter.
• Clinical Trials Controversy Spotlights Flawed System, by Jim Rosack,  Psychiatric News July 16, 2004, Volume 39 Number 14.
• July 2, 2004, Pennsylvania whistleblower lawsuit by Harvard trained psychiatrist Stefan P. Kruszewski, in Pennsylvania over Drug company/Pennsylvania State corruption involving drugging abuses, including deaths of children.
• Psychiatric Polypharmacy: A Word of Caution, June 2004, Protection and Advocacy, Inc.
• FDA Revisits Issue Of Antidepressants for Youths: New Analysis May Pressure Agency to Set Limit on Use Because of Suicide Risk, by Anna Wilde Mathews, Wall Street Journal, August 5, 2004; Page A1.
• The Biology of Mental Illness, by Jonathon Leo in Society, July/August 2004.  Dr. Leo goes through the lack of any evidence supporting the current conventional wisdom that mental illness is an actual disease. 
• FDA’s counsel accused of being too close to drug industry, Jeanne Lenzer New York, BMJ VOLUME 329 24 JULY 2004.
• Mum free after murder bid.
• Eli Lilly, Zyprexa and the Bush Family, by Bruce Levine in Z Magazine Online, May 2004 Volume 17 Number 5
• The evidence base: rock of certainty or shifting sands? by John Dewhurst, retired pharmaceutical physician, British Medical Journal, April 17, 2004, BMJ 2004;328:963 (17 April), doi:10.1136/bmj.328.7445.963
• All the Things They Taught Us That Were Wrong, by Thomas A. M. Kramer, MD Psychopharmacology Today,  2004;6(2):e19.
• Interview of Dr. Loren Mosher in the April 2004 issue of Mental Health Today (UK).
• LA Times, April 6, 2004: FDA Sat on Report Linking Suicide, Drugs
• New York Times' February 25, 2004 article on Eli Lilly and Zyprexa, which includes that "In the last year, doctors have learned that its side effects include diabetes, stroke and death."
• Allen Jones' Full Whistle-Blower Report on Drug Company influence on states' drug purchases.
  • NY Times 2/1/2004,  article, Making Drugs, Shaping the Rules about this.
• Drug report barred by FDA/Scientist links antidepressants to suicide in kids, Sunday, February 1, 2004 (SF Chronicle), Rob Waters, Special to The Chronicle
• Talking back to Prozac: David Healy was among the first psychiatrists to prescribe Prozac. Now he's one of the fiercest critics of Big Pharma's "marketing" of depression. Did his outspoken views cost him his job? By Joshua Kendall, The Boston Globe, 2/1/2004
• Antidepressants & Suicide: Lawsuits target drug makers, New Jersey Star-Ledger, Friday, January 30, 2004.
• Antidepressant Makers Withhold Data on Children, washingtonpost.com, By Shankar Vedantam, Washington Post Staff Writer, Thursday, January 29, 2004; Page A01
• Oh, behave! By Joe Studwell Financial Times, Published: January 23 2004
• Allen Jones May 8, 2004, lawsuit against the Pennsylvania Inspector General's office over retaliation for filing a previous civil rights action and for speaking out about corruption in Pennsylvania's psychiatric drug purchases.
• A Suicide Side Effect? What parents aren't being told about their kids' antidepressants.  San Francisco Chronicle, January 4, 2004.
• The Limits of Psychiatry, by Duncan Double, British Medical Journal, Vol 324: 900-904, April 15 2002.
• The psychiatric protection order for the “battered mental patient,” by Thomas Szasz. BMJ (British Medical Journal) Vol.  327 20–27 December 2003, 1449-51.
• How Drug Directory Helps Raise Tab for Medicaid and Insurers: They Pay for "Off Label" Uses if Listed -- and Drugdex Lists Great Many of Them, by David Armstrong, The Wall Street Journal, October 23, 2003.
• Over-medication: a growing crisis: Aggressive marketing a major culprit, By Lou Dobbs.  October 2, 2003.
• Does Medicaid Pay Too Much for Prescription Drugs? A Case Study of Atypical Anti-Psychotics, by Mark Duggan, University of Chicago and NBER
• Is it Prozac or Placebo.
• Psychiatric Medications, Illicit Drugs, & Alcohol, By Bruce Levine
• Frontline Investigates whether FDA Assuring Drug Safety.
• Civil Commitment Due To Mental Illness And Dangerousness: The Union Of  Law And Psychiatry Within A Treatment-Control System, by Bernadette Dallaire, Michael McCubbin, Paul Morin, and David Cohen,   Sociology of Health & Illness; Sep2000, Vol. 22 Issue 5, p679, 21p 
• Involuntary Psychiatric Interventions A Breach of the Hippocratic Oath? by Peter Stastny, MD, Ethical Human Sciences and Services, Vo. 2, No. 1: 21-41 (2000)
• SSRI discontinuation syndrome in Postgraduate Medicine
• Treatment-induced Suicide: Suicidality as a potential effect of psychiatric drugs, by Peter Lehman in, Journal of Critical Psychology, Counselling and Therepy, Vol 2, No. 1, (Spring 2002).
• The Invention of Post-Traumatic Stress Disorder and the Social Usefulness of a Psychiatric Category, by Derek Summerfield, British Medical Journal, January 15, 2001, Vol 322: 95-98.
• "What if ADHD Really Doesn't Exist?" by: Tony Zizza, AbleChild.org
• Critique of Medical-Coercive Psychiatry by Ron Leifer M.D.
• Coercive psychiatry, human rights and public participation by Richard Gosden
• The Effects of Medicating or Not Medicating on the Treatment Process by Bertram P. Karon, Ph.D.
• Three Part Series: Problems With Forced Psych Drug Treatment, by Nicholas Regush
  • Part One
  • Part Two
  • Part Three
• Trauma Within the Psychiatric Setting:  A Preliminary Empirical Report, by Karen J. Cusack, B. Christopher Frueh, Thom Hiers, Samantha Suffoletta-Maierle, and Sandy Bennett, Administration and Policy in Mental Health, Vol. 30, No. 5, May 2003 (2003)
•  Unwarranted Court Ordered Medication: A Call to Action
• The Other Drug War: Big Pharma’s 625 Washington Lobbyists from Public Citizen, July 2001.
• The Right to Refuse Treatment by Grace E. Jackson, MD
• Therapeutic Jurisprudence: Embracing a Tainted Ideal, by Arthur G. Christean
• ADHD: Total, 100% Fraud, by Fred A. Baughman Jr., Neurologist, Pediatric Neurologist, Fellow, American Academy of Neurology
• Insanity Pleas in the City Limits Monthly, May 2000.
• The MacArthur Coercion Study Executive Summary February 2001
• Mandated Community Treatment: Beyond Outpatient Commitment, by John Monahan, Ph.D, Richard J. Bonnie, LL.B, Paul S. Appelbaum, M.D., Pamela S. Hyde, J.D., Henry J. Steadman, Ph.D., and Marvin S. Swartz, M.D.
• The Rights of Users of the Mental Health System: The Tight Knot of Power, Law, and Ethics, by Michael McCubbin & David Cohen - June 1999.
• Do Psychiatric Inmates in New York Have the Right to Refuse Drugs?  An Examination of Rivers Hearings in the Brooklyn Court
• Why Psychiatric Drugs Are Always Bad by Douglas C. Smith, M.D
• The Bureaucratic Destruction of Patients' Faith in Their Doctors:  Public Psychiatry's Negative Lessons for General Medicine, by Nathaniel S. Lehrman, Bulletin of the New York Academy of Medicine, Winter 1994, Vol. 71, No. 2; 194-217.
• A Critical Analysis of the Minimal Brain Dysfunction Syndrome, by T. Richard Saunders, Professional Psychology, June 1979: 293-306.
• Hyperactive Children and the Use of Psychoactive Drugs: Treatment or Coercive Behavior Management?, by Douglas W. Springmeyer, Journal of Contemporary Law, Vol. 5:215-231 (1979)
• Twenty-Nine Medical Causes of “Schizophrenia,” Excerpted from Nutrition and Mental Illness, by the late Carl C. Pfeiffer, Ph.D., M.D.
• On Being Sane In Insane Places, by David L. Rosenham, Science, Vol. 179 (Jan. 1973), 250-258.  This is the classic study where eight of Rosenhan's friends and grad students posed as mentally ill and the psychiatrists couldn't tell (but the other patients could).

FAIR USE NOTICE: These links may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is used for non-profit educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.  Any copyright owner who objects to the use of their copyrighted material should send an e-mail to webmaster@psychrights.org.

Last modified March 31, 2025
Copyright © 2003-2025 Law Project for Psychiatric Rights. All Rights Reserved